WO2023063424A1 - Ceramide-containing composition and method for producing same - Google Patents

Ceramide-containing composition and method for producing same Download PDF

Info

Publication number
WO2023063424A1
WO2023063424A1 PCT/JP2022/038436 JP2022038436W WO2023063424A1 WO 2023063424 A1 WO2023063424 A1 WO 2023063424A1 JP 2022038436 W JP2022038436 W JP 2022038436W WO 2023063424 A1 WO2023063424 A1 WO 2023063424A1
Authority
WO
WIPO (PCT)
Prior art keywords
ceramide
composition
wine
composition according
containing composition
Prior art date
Application number
PCT/JP2022/038436
Other languages
French (fr)
Japanese (ja)
Inventor
有宏 金
裕晃 山田
アンガ サンジャヤ,
英一 金
敦史 山津
武祚 金
Original Assignee
株式会社ファーマフーズ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2022094514A external-priority patent/JP2023059809A/en
Application filed by 株式会社ファーマフーズ filed Critical 株式会社ファーマフーズ
Publication of WO2023063424A1 publication Critical patent/WO2023063424A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/164Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/87Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/18Antioxidants, e.g. antiradicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Definitions

  • the present invention relates to compositions containing ceramide. More specifically, it relates to compositions containing polyphenols and ceramides, especially free ceramides, and methods of making the same.
  • Ceramide is a type of sphingolipid and a major component of stratum corneum intercellular lipids. Ceramide is expected to have effects such as skin barrier effect (surface protection), moisturizing effect, moisture regulation, elasticity retention, collagen protection, and antioxidant effect when applied to the skin or taken orally. Many cosmetic products and functional foods are provided.
  • ceramides plant-derived ceramide raw materials have been put into practical use from many plants such as konnyaku and rice, and all of them contain glucosylceramide (sugar ceramide) as the main component and are mainly used as raw materials for food.
  • these glucosylceramides are non-human ceramides and differ in structure from human ceramides.
  • human ceramide is in a free form (free ceramide) in which sugars and phosphoric acids are not bound, and is not contained in normal living cells, so it is a component that hardly exists in the natural world. Therefore, the development of free ceramides derived from natural products is desired.
  • the present inventors have found a novel composition useful for health and/or beauty, containing polyphenols and ceramide (especially free ceramide).
  • the present inventors also found that a composition containing ceramide (particularly, free ceramide) in addition to polyphenols can be obtained by subjecting fermented lees produced during wine brewing to a specific treatment. rice field. Therefore, the present invention provides a composition derived from a natural product containing such polyphenols and ceramides, and a method for producing the same.
  • (Item 1) A cosmetic and/or oral composition containing polyphenols and ceramides.
  • (Item 2) The composition according to the preceding items, wherein the ceramide comprises free ceramide and glucosylceramide.
  • (Item 3) A composition according to any one of the preceding items, wherein the composition comprises at least about 1% by weight of free ceramide.
  • (Item 4) A composition according to any one of the preceding items, wherein said composition comprises at least about 1% by weight of glucosylceramide.
  • (Item 5) A composition according to any one of the preceding items, wherein the composition comprises at least about 1% by weight of polyphenols.
  • (Item 10) The composition according to any one of the above items, which is for food.
  • (Item 11) The composition according to any one of the above items, which is used for cosmetics.
  • (Item 12) The composition according to any one of the above items, wherein the polyphenol and the ceramide are derived from wine fermentation lees.
  • (Item 13) A composition according to any one of the preceding items for promoting keratinocyte differentiation.
  • (Item 14) A composition according to any one of the preceding items for promoting ceramide synthesis.
  • (Item A1) A ceramide-containing composition derived from wine fermentation lees.
  • (Item A2) A composition according to any one of the preceding items, wherein the ceramide-containing composition comprises at least about 1% by weight of free ceramide.
  • compositions according to any one of the preceding items, wherein the ceramide-containing composition comprises at least about 1% by weight of glucosylceramide.
  • compositions according to any one of the preceding items, wherein the ceramide-containing composition comprises at least about 1% by weight of polyphenols.
  • the weight ratio of free ceramide, glucosylceramide, and polyphenol in the composition is about 0.7 to about 2.4: about 1.0: about 1.4 to about 11.0. 13.
  • composition according to any one of the preceding items wherein the weight ratio of free ceramide, glucosylceramide and polyphenol in the ceramide-containing composition is about 1.0: about 1.0: about 1.0.
  • composition according to any one of the preceding items wherein the ceramide-containing composition has a pH of less than about 5.
  • composition according to any one of the preceding items comprising at least about 10 mg resveratrol per about 100 g.
  • the composition according to any one of the above items, which is for food. (Item A10) The composition according to any one of the above items, which is used for cosmetics.
  • (Item A11) A composition according to any one of the preceding items for promoting keratinocyte differentiation.
  • (Item A12) A composition according to any one of the preceding items for promoting ceramide synthesis.
  • (Item B1) A method for producing a ceramide-containing composition, comprising: A step of washing the wine fermented lees; and extracting the residue obtained by said washing with a polar solvent.
  • the method according to the preceding items, wherein the polar solvent comprises ethanol.
  • (Item B3) A method according to any one of the preceding items, wherein the ethanol concentration is about 95%.
  • (Item B4) A method according to any one of the preceding items, wherein the washing step is performed with water.
  • (Item B5) A method according to any one of the preceding items, further comprising the step of pH-adjusting the extract obtained by the step of extracting.
  • (Item B6) A method according to any one of the preceding items, wherein said pH adjustment is performed with tartaric acid or citric acid.
  • (Item C1) A method for promoting keratinocyte differentiation, comprising administering a composition according to any one of the preceding items.
  • (Item C2) A method for promoting ceramide synthesis, comprising administering a composition according to any one of the preceding items.
  • a composition containing polyphenols and ceramides, especially human-type free ceramides can be obtained.
  • a composition containing polyphenols and ceramides, especially human-type free ceramides, can be obtained.
  • fermented wine lees when such a composition is obtained from fermented wine lees, it uses fermented wine lees, which is a highly safe natural material. It has excellent safety and high utility value without adversely affecting the environment.
  • FIG. 1 is a graph according to an embodiment showing the difference between the composition of ceramide molecular species in wine starch and the composition of ceramide molecular species in soybean.
  • FIG. 2 is a graph according to one embodiment showing the difference between the amount of ceramide obtained from wine lees extract and the amount of ceramide obtained from wine.
  • FIG. 3 is a schematic diagram showing a process flow for producing a ceramide-containing composition, which was used to examine the washing step in the process for producing a ceramide-containing composition. The left side of FIG. 3 shows the case where the ceramide extract was extracted from the starting wine lees with 95% ethanol, and the right side of FIG. 3 shows the case where the starting wine lees were washed with 50% ethanol.
  • FIG. 3 is a schematic diagram showing a process flow for producing a ceramide-containing composition, which was used to examine the washing step in the process for producing a ceramide-containing composition. The left side of FIG. 3 shows the case where the ceramide extract
  • FIG. 4 is a graph according to one embodiment showing differences in composition of ceramide-containing compositions due to differences in washing processes.
  • FIG. 4 shows the content (mg) of each component.
  • FIG. 5 shows the difference in the composition of the ceramide-containing composition due to the difference in the washing process (when the ceramide extract is extracted from the raw wine lees with 95% ethanol and when the raw wine lees are washed with 50% ethanol).
  • 4 is a graph according to one embodiment;
  • FIG. 5 shows the ratio of each component.
  • FIG. 6 is a schematic diagram showing a process flow for producing a ceramide-containing composition, which was used to examine the washing step in the process for producing a ceramide-containing composition.
  • FIG. 7 is a graph according to an embodiment showing the difference in the composition of the ceramide-containing composition due to the difference in the washing process (when the raw wine starch was washed with water, 10%, 30%, or 50% ethanol). .
  • the left side of FIG. 7 shows the ratio of each component, and the right side of FIG. 7 shows the content (mg) of each component.
  • FIG. 8 is a schematic diagram showing a process flow for producing a ceramide-containing composition, which was used to examine the washing step in the process for producing a ceramide-containing composition. It shows the case where the raw wine lees are washed with water at 40°C or 60°C.
  • FIG. 8 is a schematic diagram showing a process flow for producing a ceramide-containing composition, which was used to examine the washing step in the process for producing a ceramide-containing composition. It shows the case where the raw wine lees are washed with water at 40°C or 60°C.
  • FIG. 9 is a graph according to one embodiment showing the difference in the composition of the ceramide-containing composition due to the difference in the washing process (when the raw wine starch is washed with water at 40° C. or 60° C.).
  • the left side of FIG. 9 shows the ratio of each component, and the right side of FIG. 9 shows the content (mg) of each component.
  • FIG. 10 is a schematic diagram showing a process flow for producing a ceramide-containing composition, which was used to examine the washing step in the process for producing a ceramide-containing composition. Raw wine lees are shown washed with water for 30, 60, or 180 minutes.
  • FIG. 10 is a schematic diagram showing a process flow for producing a ceramide-containing composition, which was used to examine the washing step in the process for producing a ceramide-containing composition. Raw wine lees are shown washed with water for 30, 60, or 180 minutes.
  • FIG. 11 is a graph according to one embodiment showing the difference in the composition of the ceramide-containing composition due to the difference in the washing process (when the raw wine lees are washed with water for 30, 60, or 180 minutes).
  • the left side of FIG. 11 shows the ratio of each component, and the right side of FIG. 11 shows the content (mg) of each component.
  • FIG. 12 is a schematic diagram showing a process flow for producing a ceramide-containing composition, which was used to examine the washing step in the process for producing a ceramide-containing composition. It shows the case where the raw material wine sediment was washed with 10 times, 8.3 times, and 6.7 times the amount of water.
  • FIG. 12 is a schematic diagram showing a process flow for producing a ceramide-containing composition, which was used to examine the washing step in the process for producing a ceramide-containing composition. It shows the case where the raw material wine sediment was washed with 10 times, 8.3 times, and 6.7 times the amount of water.
  • FIG. 13 shows the difference in the composition of the ceramide-containing composition due to the difference in the washing process (when the raw wine starch was washed with 10 times, 8.3 times, and 6.7 times the amount of water) according to one embodiment.
  • the left side of FIG. 11 shows the ratio of each component, and the right side of FIG. 11 shows the content (mg) of each component.
  • FIG. 14 is a schematic diagram showing a process flow for producing a ceramide-containing composition, which was used to examine pH adjustment in the process for producing a ceramide-containing composition. It shows the case where tartaric acid, citric acid, or sodium carbonate is added to the ceramide extract extracted from the raw wine lees.
  • FIG. 15 is a photograph according to one embodiment showing the difference in color of the ceramide-containing composition due to the difference in pH.
  • FIG. 16 is a graph according to one embodiment showing the effect of a ceramide-containing composition on human epidermal cell proliferation.
  • human epidermal cells Hacat cells
  • FIG. 17 is a graph according to one embodiment showing the amount of resveratrol contained in red wine, wine lees (wine crystals), and ceramide-containing composition (wine ceramide).
  • FIG. 18 is a graph showing mRNA expression levels of differentiation markers (Pro-Filaggrin and Loricrin) when wine ceramide according to one embodiment of the present invention was added to a human epidermal keratinocyte Hacat cell line and cultured for 72 hours.
  • FIG. 19 is a graph showing the mRNA expression level of ceramide synthesis pathway marker (SPT: Serine-Palmitoyl Transferase) when wine ceramide according to one embodiment of the present invention was added to human epidermal keratinocyte Hacat cell line and cultured for 72 hours. is.
  • SPT Serine-Palmitoyl Transferase
  • FIG. 20 shows a differentiation marker (Pro-Filaggrin) and ceramide synthesis pathway when wine ceramide, glucosylceramide, and free ceramide according to one embodiment of the present invention were added to human epidermal keratinocyte Hacat cell line and cultured for 72 hours. It is a graph which shows the mRNA expression level of a marker (SPT).
  • FIG. 21 shows that wine ceramide according to one embodiment of the present invention and ceramides obtained from raw materials other than wine (rice ceramide, pine ceramide, and konjac ceramide) were added to human epidermal keratinocyte Hacat cell line, and 72 hours.
  • FIG. 1 is a graph showing mRNA expression levels of a differentiation marker (Pro-Filaggrin) and a ceramide synthesis pathway marker (SPT) when cultured.
  • FIG. 1 is a graph showing mRNA expression levels of a differentiation marker (Pro-Filaggrin) and a ceramide synthesis pathway marker (SPT) when cultured.
  • FIG. 22 is a photograph of a cell section when wine ceramide according to one embodiment of the present invention was added to 3D-cultured keratinocytes and
  • FIG. 23 is a photograph of a cell section when wine ceramide according to one embodiment of the present invention was added to 3D-cultured keratinocytes and cultured for 48 hours.
  • the amount of ceramide in the cell section was immunostained with an anti-ceramide antibody and observed under a phase-contrast microscope.
  • Wine ceramide according to one embodiment of the present invention significantly increased the amount of ceramide in the skin.
  • Ceramide is a kind of sphingolipid and refers to a group of compounds in which sphingosine and fatty acid are amide bonded.
  • Ceramide also includes ceramide derivatives. Ceramide is a compound having a structure (--NH--CO--) in which an amino group (--NH 2 ) of a sphingoid base is bonded to a carboxyl group (--COOH) of a fatty acid. The alcoholic hydroxyl group (--OH) of the sphingoid base of ceramide is further combined with a polar group such as sugar and phosphoric acid to form glycosphingolipids and phosphosphingolipids, respectively.
  • a polar group such as sugar and phosphoric acid
  • those bound with sugars are particularly called glycosylceramides, and particularly when the sugar is glucose, they are called glucosylceramides.
  • Ceramide is called free ceramide when sugar, phosphoric acid, etc. are not bound to ceramide. Since free ceramide is generally an intermediate metabolite in the sphingolipid synthesis system, it exists only in minute amounts, especially in animals and plants.
  • Galactosylceramide, glucosylceramide, and sphingomyelin, in which ceramide is bound with sugar or phosphoric acid, are extracted from animals and plants, but because the sugar or phosphoric acid is bound, they are not found in intercellular lipids. orientation is different from that of free ceramide.
  • polyphenol is a general term for compounds having multiple phenolic hydroxyl groups in the molecule, specifically flavonols, flavones, isoflavones, tannins, catechins, quercetin, anthocyanins, anthocyanidins, leucoanthocyanidins. , proanthocyanidins, propyl gallate, catechin, rutin, quercetin, ferulic acid, resveratrol, procyanidins, theaflavin, curcumin, pycnogenol, rosmarinic acid, ellagic acid, quinic acid, chlorogenic acid, hydroxytyrosol and the like.
  • washing refers to washing away and removing impurities by stirring and mixing wine fermented lees (wine lees) and liquid.
  • extraction means separating the analyte contained in the solution from other impurities, and is also referred to as solvent extraction or liquid-liquid extraction.
  • a cosmetic and/or oral composition containing polyphenols and ceramides is provided.
  • a ceramide-containing composition derived from wine fermentation lees is provided. Since both the cosmetic and/or oral intake composition containing polyphenol and ceramide and the ceramide-containing composition derived from fermented wine lees contain ceramide, they are not particularly mentioned in the present specification. Except for this, it can be collectively referred to as a "ceramide-containing composition". Moreover, in this specification, the ceramide-containing composition of the present invention may be referred to as "wine ceramide".
  • Ceramide is a type of sphingolipid and includes a group of compounds in which sphingosine and fatty acid are amide bonded.
  • ceramide is a non-permeable compound having one or more long-chain straight and/or branched alkyl or alkenyl groups, at least two hydroxyl groups, and one or more amide groups (and/or amino groups) in the molecule. It may be an ionic amphiphilic substance. Ceramide may also be a substance in which a phosphatidylcholine residue or a sugar residue is bound to the hydroxyl group of the nonionic amphiphilic substance (a type of so-called ceramide derivative).
  • ceramides include free ceramides and glucosylceramides.
  • ceramides include plant-derived ceramides, preferably wine fermentation lees-derived ceramides.
  • the free ceramide is not particularly limited as long as it can be used for cosmetics, external skin preparations, or food. 6I, and natural free ceramides such as ceramide 6II.
  • the ceramide-containing composition of the present invention can be obtained using materials that do not adversely affect the human body, so safety is important for food and skin applications. It is effective as a raw material for the intended use. In addition, since it contains human-type free ceramide, it is also suitable as a raw material for foods such as health foods.
  • the ceramide-containing composition of the present invention can contain only one type of these free ceramides or a combination of two or more types in any mixing ratio.
  • the ceramide in the ceramide-containing composition of the present invention has a barrier function that prevents moisture from evaporating from the skin, a function that restores the barrier function, a function that imparts firmness and elasticity to the hair, a function that promotes exfoliation of keratin, a function that smoothes the skin, and a skin
  • the ceramide-containing composition of the present invention has various functions such as a function of exerting a moisturizing effect when applied to hair and a function of exerting a ceramide production promoting effect, and the function of the ceramide-containing composition of the present invention is one of these functions or It is not limited to two or more, and may have a function as a ceramide other than these functions.
  • the ceramide-containing composition of the present invention may be applied to the skin or used as food. In either case, it is possible to enjoy the above-mentioned functions including moisturizing of the skin, improvement of dark spots and wrinkles, protection against ultraviolet rays, and the like.
  • the ceramide-containing composition of the present invention promotes differentiation of keratinocytes in the skin and/or promotes de novo synthesis of ceramide by being applied to the skin and/or ingested as food. can be promoted.
  • the ceramide-containing composition of the present invention can, for example, increase gene expression of keratinocyte differentiation markers.
  • the keratinocyte differentiation marker is not particularly limited as long as it can confirm keratinocyte differentiation, but preferably includes a genetic marker. factor (NMF)) and Loricrin (a protein that serves as a framework for normal formation of the stratum corneum).
  • the ceramide-containing composition of the present invention can promote ceramide synthesis, for example, by enhancing the expression of genes associated with ceramide synthesis in the ceramide synthesis pathway.
  • De novo synthesis of ceramide is based on Serine + Palmitoyl CoA ⁇ 3-keto-sphinganine ⁇ Sphinganine ⁇ Dihydroceramide ⁇ Ceramide is known.
  • the differentiation marker of the ceramide synthesis pathway is not particularly limited as long as it is involved in the ceramide synthesis pathway, but preferably includes a genetic marker. (enzyme). SPT catalyzes the conversion of Serine+Palmitoyl CoA to 3-keto-sphinganine in the ceramide synthesis pathway.
  • the ceramide-containing composition of the present invention can increase skin thickness and promote skin turnover by promoting the increase and differentiation of keratinocytes.
  • the ceramide-containing composition of the present invention comprises at least about 0.01 wt% or more free ceramide, preferably at least about 0.1 wt% or more, at least about 0.3 wt% or more. , at least about 0.5% by weight or more, or at least about 0.8% by weight or more of free ceramide, and more preferably at least about 1% by weight or more of free ceramide.
  • the ceramide-containing composition of the present invention comprises at least about 0.01 wt% or more of glucosylceramide, preferably at least about 0.1 wt% or more, at least about 0.3 wt% or more. , at least about 0.5% by weight or more, or at least about 0.8% by weight or more of glucosylceramide, and more preferably at least about 1% by weight or more of glucosylceramide.
  • Polyphenol is a compound having a plurality of phenolic hydroxyl groups in the molecule, and the type of polyphenol contained in the composition of the present invention is not particularly limited. Examples include flavonol, flavone, isoflavone, tannin, catechin, quercetin, Anthocyanin, anthocyanidin, leucoanthocyanidin, proanthocyanidin, propyl gallate, catechin, rutin, quercetin, ferulic acid, resveratrol, procyanidin, theaflavin, curcumin, pycnogenol, rosmarinic acid, ellagic acid, quinic acid, chlorogenic acid, hydroxytyrosol etc. In the composition of the present invention, these polyphenols may be contained singly or in combination of two or more.
  • the polyphenol content in the compositions of the present invention is at least about 0.01 wt% or more, preferably at least about 0.1 wt% or more, at least about 0.3 wt% or more, at least about It can be at least 0.5% by weight, or at least about 0.8% by weight or more, and more preferably at least about 1% by weight or more.
  • the composition of the present invention may comprise resveratrol as a polyphenol in an amount of at least about 1 mg, at least about 3 mg, at least about 5 mg, at least about 7 mg per about 100 g of the composition of the present invention. , or at least about 10 mg resveratrol.
  • ceramide as a food raw material, many plant-derived ceramides such as konjac and rice are produced, but since all of them contain glucosylceramide as the main component, the ceramide-containing composition of the present invention has the same level of glucosylceramide. It is useful in that it contains less or more free ceramide.
  • compositions of the present invention contain ceramides and polyphenols in a weight ratio of total ceramides: polyphenols of about 1.0: about 0.5 to about 5.0, preferably about 1.0: It can be from about 0.7 to about 4.0.
  • a method for producing a ceramide-containing composition comprising the steps of washing wine fermented lees and extracting the residue obtained by the washing with a polar solvent.
  • the method for producing a ceramide-containing composition of the present invention comprises washing wine fermentation lees (bitartrate) obtained during wine brewing, and then extracting the residue with a polar solvent to obtain a fermented product extract. Characterized by There are no particular restrictions on the grape variety, the type of yeast, or the wine production method used as the raw material for the wine fermented lees. It can be used as wine fermentation lees. Wine yeast used for wine fermentation is not particularly limited, but natural yeast and cultured yeast can be used. Therefore, no matter what type of wine lees is used as a starting material, a composition with an increased content of ceramide or glucosylceramide can be produced by the method for producing a ceramide-containing composition of the present invention.
  • polar solvents such as water, methanol, ethanol, isopropyl alcohol, 1,3-butylene glycol, ethylene glycol, propylene glycol, glycerin, and ethyl acetate can be used as polar solvents. Two or more of these solvents may be mixed.
  • the ceramide-containing composition of the present invention can be efficiently extracted by using ethanol or hydrous ethanol, which is a mixture of ethanol and water, as the polar solvent.
  • the concentration of ethanol is not particularly limited, for example, the ethanol concentration can be about 10% to about 99% (wt/wt), preferably the ethanol concentration is at least about 70%. % or more, about 75% or more, about 80% or more, about 85% or more, about 90% or more, about 93% or more, about 95% or more, about 98% or more, about 99% or more (wt/wt) can be done.
  • the extraction temperature in the extraction step is about 30°C to about 80°C, preferably about 40°C to about 60°C.
  • the extraction time can be about 1 hour to about 8 hours, preferably about 3 hours to about 6 hours.
  • stirring extraction can be performed using an oar-type or propeller-type stirrer as the extraction method.
  • a solvent such as ethanol
  • the mixture is filtered, and the filtrate can be used as a ceramide fraction (the ceramide-containing composition of the present invention).
  • the scale of extraction can be set appropriately, so in another embodiment, a beaker is placed in a water bath, and wine lees and a solvent (such as ethanol) are stirred in the beaker for extraction. .
  • the wine fermentation lees can be washed with water in the washing step.
  • washing can be performed while stirring the fermented wine lees and water using an oar-type or propeller-type agitator.
  • the fermented wine lees and water can be stirred while being heated. After stirring for a period of time, it can be filtered and the residue used in the extraction process. Examples of water include purified water, sterilized water, and tap water. Purified water or sterilized water is preferable because it contains few impurities.
  • the washing temperature can be about 30°C to about 80°C, preferably about 40°C to about 60°C.
  • the cleaning time can be about 5 minutes to about 6 hours, preferably about 1 hour to about 2 hours.
  • the method for producing the ceramide-containing composition of the present invention can further adjust the pH of the extract obtained by the extraction step with a polar solvent.
  • a polar solvent By such pH adjustment, the color of the obtained ceramide-containing composition can be adjusted, and preferably a desired wine color can be obtained.
  • Such pH adjustment can be performed with an acid or alkali, and the type of acid or alkali is selected within a range that does not impair the effects of the ceramide-containing composition of the present invention.
  • food for specified health use, supplements, pharmaceuticals, quasi-drugs, or external skin preparations but not limited to, for example, phosphoric acid, tartaric acid, citric acid, or sodium carbonate can be done.
  • the ceramide-containing compositions of the present invention can be pH-adjusted for color depending on the desired application, wherein the pH-adjustment as described above reduces the pH of the ceramide-containing composition to, for example, less than about 5. , less than about 4.8, less than about 4.0, or less than about 3.5.
  • the extraction, separation, purification, identification, etc. of the ceramide-containing composition of the present invention a wide range of normal operations can be applied. It is also possible to adjust the pH, mix with desired excipients as necessary, and perform concentration, heat sterilization, freeze-drying, and the like.
  • the ceramide-containing composition of the present invention is obtained by washing wine fermented lees (wine lees) with preferably about 10 times the amount of water at about 60°C for about 1 hour, and then removing the residue. Preferably, it can be obtained by performing extraction with an ethanol solution of about 95% at about 40° C. for about 6 hours. Further, in one preferred embodiment of the present invention, the ceramide-containing composition of the present invention can adjust the pH of the extract obtained as described above to less than about 4.0.
  • the ceramide-containing composition of the present invention is mixed with an excipient such as cyclodextrin, further concentrated by replacing ethanol with water, heat sterilized at about 120 ° C., It can be lyophilized and powdered.
  • the ceramide-containing composition of the present invention is obtained by the production method described above, and contains glucosylceramide, free ceramide, and polyphenol at a weight ratio of about 1.0:1. .0: about 1.0 ratio. Moreover, in one preferred embodiment of the present invention, the ceramide-containing composition of the present invention can contain at least about 10 mg of resveratrol per about 100 g of the composition of the present invention by being obtained by the method described above. .
  • the ceramide-containing composition produced by the method of the present invention can be applied or blended for various uses.
  • Applications include, for example, cosmetics, pharmaceuticals, reagents, and compositions for oral intake (eg, health foods, foods with function claims, foods for specified health uses, supplements, and foods for specific uses).
  • the product containing the ceramide-containing composition of the present invention may contain excipients, carriers, additives, etc., the types of which are commonly used and pharmaceutically acceptable It is not particularly limited as long as it is a substance, and the blending amount thereof can be changed as appropriate.
  • excipients include sodium chloride, sodium citrate, etc.
  • carriers include sterilized water, physiological saline, and various buffer solutions. Preservatives, preservatives and the like can be mentioned.
  • the dosage form of the pharmaceutical containing the ceramide-containing composition of the present invention is not particularly limited, and may be appropriately selected as necessary.
  • Oral agents such as granules and powders, and parenteral agents such as injections, suppositories, and ointments can be used.
  • the amount of the ceramide-containing composition of the present invention in these pharmaceuticals is not particularly limited, and can be appropriately set according to the type and application of the pharmaceutical.
  • compositions for oral intake containing the ceramide-containing composition of the present invention optionally contain dextrin. , lactose, starch, and other excipients, flavors, pigments, gelatin, etc., and the ceramide-containing composition of the present invention can be blended.
  • the amount of the ceramide-containing composition of the present invention blended in these compositions for oral intake is not particularly limited, and can be appropriately set according to the type and use of the composition for oral intake.
  • these compositions for oral ingestion can contain various ingredients depending on the type.
  • the ceramide-containing composition of the present invention can also be added to foods and drinks that are normally consumed.
  • the ceramide-containing composition of the present invention can also be incorporated into external skin preparations including cosmetics, pharmaceuticals, and quasi-drugs.
  • the ceramide-containing composition of the present invention can be used for skin lotions, milky lotions, creams, lotions, soaps, facial cleansers, bath agents, eau de colognes, cosmetic oils, suntan/sunscreen lotions, powders, foundations, perfumes, packs, eye creams, etc. It can be incorporated into creams, eye shadows, mascaras, eyeliners, lipsticks, lip balms, shampoos, rinses, hair dyes, ointments, creams, liquids for external use, and the like.
  • external skin preparations including cosmetics, pharmaceuticals, and quasi-drugs
  • ceramide-containing composition of the present invention contain:
  • Various ingredients used in usual external preparations for skin e.g., surfactants, fatliquors, hair protectants, moisturizers, polymers, UV absorbers, sequestering agents, solvents, pH adjusters, vitamins, oxidation Antioxidants, antioxidant aids, preservatives, fragrances, oily components, higher alcohols, fatty acids, polar lipids, antibacterial components, viscosity modifiers, pigments, and the like can be blended.
  • the ceramide-containing composition of the present invention is spray-dried, freeze-dried, or vacuum-dried, and then made into powder, granules, or a solution for use in external skin preparations, food and drink, pharmaceuticals, and the like. can be easily included.
  • Example 1 Ceramide molecular species in wine sediment
  • 50 g of wine lees (Bitartrate) was washed with water at 60° C. for 1 hour to obtain a residue.
  • the residue was extracted with 95% ethanol at 40° C. for 6 hours.
  • the composition of ceramide molecular species in this extract was compared with ceramide molecular species similarly obtained from soybean.
  • the results are shown in FIG. As can be seen from these results, ceramide obtained from soybean is only glucosylceramide and does not contain free ceramide, while ceramide obtained from wine starch contains both glucosylceramide and free ceramide.
  • soybean ceramide pure soybean-derived glucosylceramide manufactured by Nagara Science Co., Ltd. was used.
  • Fig. 2 shows the results of confirming the ceramide molecular species and their amounts contained in the wine lees extract and the wine itself. From this result, it can be seen that wine itself contains neither free ceramide nor glucosylceramide, but the extract obtained from wine lees contains both free ceramide and glucosylceramide.
  • FIG. 3 shows a method for producing the wine lees extract (“W ceramide extract” in the figure) investigated in this example.
  • W ceramide extract was extracted from wine starch using 95% ethanol (60° C., 6 hours), and then W ceramide extract was further extracted from the residue using 60% ethanol (60° C., 6 hours). 3 hours).
  • FIG. 3 shows a method for producing the wine lees extract (“W ceramide extract” in the figure) investigated in this example.
  • W ceramide extract was extracted from wine starch using 95% ethanol (60° C., 6 hours), and then W ceramide extract was further extracted from the residue using 60% ethanol (60° C., 6 hours). 3 hours).
  • 60% ethanol 60° C., 6 hours
  • FIGS. 4 and 5 show the content (mg) of each component, and FIG. 5 shows the ratio of each component.
  • Example 3 Examination of cleaning process 2
  • Example 2 it was found that impurities can be removed more effectively by washing the wine lees than by first extracting it with ethanol. Therefore, washing solutions were investigated.
  • wine lees were washed with water, 10% ethanol, 30% ethanol, or 50% ethanol (both at 40 ° C. for 3 hours), and then 95% ethanol was removed from the residue after washing. was used to extract W ceramide extract (40° C., 6 hours) (FIG. 6). The results are shown in FIG.
  • Example 4 Examination of washing temperature
  • wine lees were washed with water at 40° C. or 60° C. (both 500 ml, 3 hours), and then W ceramide extract was extracted from the residue after washing with 95% ethanol. (40° C., 6 hours) (FIG. 8).
  • FIG. 8 The results are shown in FIG. As can be seen from this figure, contaminants (indicated by "others" in the figure) were significantly reduced when washed at 60°C compared to when washed at 40°C.
  • Example 5 Examination of washing time
  • Example 4 it was found that washing the wine lees with water at 60° C. was optimal, and therefore the washing time was investigated.
  • wine lees were washed for 30 minutes, 60 minutes, and 180 minutes (500 ml, 60° C. in each case), and then W ceramide extract was extracted from the residue after washing using 95% ethanol ( 40° C., 6 hours) (FIG. 10). The results are shown in FIG.
  • Example 6 Examination of amount of water added
  • 50 g, 60 g, and 75 g of wine lees were washed with 500 ml of water (10 times water, 8.3 times water, and 6.7 times water, each at 60° C. for 1 hour), Thereafter, W ceramide extract was extracted from the residue after washing using 95% ethanol (40° C., 6 hours) (FIG. 12). The results are shown in FIG.
  • Example 7 Examination of pH adjustment
  • tartaric acid, citric acid, or sodium carbonate was added to the W ceramide extract obtained by ethanol extraction, and then an excipient (cyclodextrin) was added, followed by freeze-drying into powder. The powder color in the case was confirmed (Fig. 14). The results are shown in FIG.
  • Example 8 Cell proliferation test
  • HaCaT cells human epidermal cells
  • Human epidermal cells HaCaT cells
  • a medium containing various concentrations of ceramide extract obtained from wine lees were cultured in a medium containing various concentrations of ceramide extract obtained from wine lees.
  • Cell proliferation was measured after 3 hours of culture.
  • cell proliferation It was measured using Counting Kit 8 (manufactured by Dojin Kagaku Kenkyusho Co., Ltd.). The results are shown in FIG.
  • the ceramide extract obtained from wine lees promotes cell proliferation in keratinocyte cells (HaCaT cells) (see 0.01-1 ⁇ g/mL addition group in FIG. 16).
  • Example 9 resveratrol amount measurement
  • the amount of resveratrol in the ceramide-containing composition of the present invention was measured.
  • Resveratrol is one of polyphenols with antioxidant action and is known as a component contained in red wine.
  • effects such as preventing cell oxidation and improving skin elasticity are expected.
  • the amount of resveratrol contained in red wine, wine lees (wine crystals), and ceramide-containing composition (wine ceramide) was measured using HPLC. The results are shown in FIG.
  • the amount of resveratrol contained in the ceramide-containing composition (wine ceramide) of the present invention is significantly increased compared to the amount of resveratrol contained in red wine or wine sediment (wine crystals). It can be seen that
  • Example 10 Expression enhancement effect of various gene markers by wine ceramide
  • HaCaT human keratinocyte cell line
  • DMEM medium containing 10% FBS (37° C., 5% CO 2 ).
  • FBS-free DMEM medium
  • Ceramides derived from other raw materials were purchased from manufacturers listed in Table 1.
  • Wine ceramides were extracted by the optimized procedure shown in Examples 2-6 (water wash with 10 times water at 60°C for 60 minutes and 95% ethanol extraction at 40°C for 6 hours).
  • a DMEM medium (FBS-free) supplemented with DMSO to a final concentration of 0.1% was used as a control. After culturing for 72 hours, mRNA was collected from the cells and cDNA was prepared. Using this, the mRNA expression of each marker was measured by qPCR. Each marker evaluated is as follows. ⁇ Differentiation markers; Pro-Filaggrin, Loricrin ⁇ Ceramide synthesis pathway marker; Serine-Palmitoyl Transferase
  • wine ceramide increased the mRNA expression level of the ceramide synthesis pathway marker SPT: Serine-Palmitoyl Transferase (an enzyme of the ceramide de novo synthesis pathway) compared to the control. This indicates that wine ceramide promotes the ceramide synthesis pathway.
  • SPT Serine-Palmitoyl Transferase
  • FIG. 20 also shows the Pro-filagrin mRNA expression level and SPT mRNA expression level when comparing the wine ceramide of the present invention with glucosylceramide and free ceramide.
  • the amounts of glucosylceramide and free ceramide added were calculated based on the equivalent amounts of glucosylceramide and free ceramide contained in wine ceramide. /mL was used.
  • Glucosylceramide and free ceramide used were those isolated from wine ceramide. As can be seen from this figure, wine ceramide is more effective in increasing the respective mRNA expression levels than glucosylceramide alone or free ceramide alone.
  • FIG. 21 also shows the Pro-Filaggrin mRNA expression level and SPT mRNA expression when comparing the wine ceramide of the present invention with each ceramide obtained from raw materials other than wine (rice ceramide, pine ceramide, and konjac ceramide). indicated the quantity.
  • the composition of each ceramide is as shown in Table 1. As can be seen from this figure, wine ceramide is more effective in increasing the respective mRNA expression levels than rice ceramide or pine ceramide.
  • Example 11 Effect of wine ceramide on keratinocytes
  • the efficacy of wine ceramide was evaluated in primary cultured keratinocytes cultured in 3D using Transwell.
  • the same wine ceramide as in Example 10 was used.
  • a culture medium containing wine ceramide was added to each of the stratum corneum side (upper well) and the basement membrane side (bottom well) of the transwell for a predetermined period of time and cultured.
  • the cells were cultured in a medium containing 0.1% DMSO. After culturing in each medium, frozen sections of 3D-cultured primary cultured keratinocytes were prepared and subjected to hematoxylin-eosin staining and immunostaining using an anti-ceramide antibody.
  • the hematoxylin/eosin-stained sections were observed under a phase-contrast microscope, and the results of measuring the thickness of the epidermal layer are shown in FIG.
  • the wine ceramide treatment increases the thickness of the skin.
  • skin thickness it is known that skin turnover decreases and becomes thinner with aging. may have also promoted
  • Sections immunostained with an anti-ceramide antibody were also observed under a fluorescence microscope, and the results of measuring the ceramide content in the epidermal layer are shown in FIG.
  • the immunostained area is enlarged and the amount of ceramide is increased compared to the control group.
  • the mRNA expression level of the ceramide synthesis pathway marker (SPT) was increased.
  • SPT ceramide synthesis pathway marker
  • the present invention can provide a ceramide-containing composition derived from wine fermentation lees. Moreover, according to the method of the present invention, it is possible to stably extract a ceramide composition from wine fermentation lees while removing contaminants, and to control the color of the ceramide composition. Furthermore, the ceramide composition of the present invention contains free ceramide and uses highly safe natural materials such as wine fermented lees. It is useful in fields such as cosmetics, pharmaceuticals, and quasi-drugs because it has excellent safety.

Abstract

Provided is a composition containing a ceramide derived from a natural substance. The present invention provides a composition containing a polyphenol and a ceramide. The invention of the present application further provides a composition containing a ceramide derived from wine fermentation lees. Also provided is a method for producing a ceramide-containing composition, the method comprising a step for washing wine fermentation lees and a step for extracting the resulting washing residue using a polar solvent.

Description

セラミド含有組成物、およびその製造方法Ceramide-containing composition and method for producing the same
 本発明はセラミドを含有する組成物に関する。より具体的には、ポリフェノールおよびセラミド、特にフリーセラミドを含有する組成物、及びそれを製造する方法に関する。 The present invention relates to compositions containing ceramide. More specifically, it relates to compositions containing polyphenols and ceramides, especially free ceramides, and methods of making the same.
 セラミドはスフィンゴ脂質の一種であり、角層細胞間脂質の主成分である。セラミドは、皮膚への塗布や経口摂取により、皮膚のバリヤー効果(表面保護)をはじめ、保湿効果、水分調節、弾力性保持、コラーゲン保護、酸化防止等の効果が期待されることから、セラミドを配合した化粧品や機能性食品が多数提供されている。  Ceramide is a type of sphingolipid and a major component of stratum corneum intercellular lipids. Ceramide is expected to have effects such as skin barrier effect (surface protection), moisturizing effect, moisture regulation, elasticity retention, collagen protection, and antioxidant effect when applied to the skin or taken orally. Many cosmetic products and functional foods are provided.
 セラミドの中でも植物由来のセラミド原料は、コンニャクやコメなど多くの植物から実用化されており、いずれもグルコシルセラミド(糖セラミド)を主成分とし、主に食品用原料として使用されている。 Among ceramides, plant-derived ceramide raw materials have been put into practical use from many plants such as konnyaku and rice, and all of them contain glucosylceramide (sugar ceramide) as the main component and are mainly used as raw materials for food.
 一方で、これらのグルコシルセラミドは非ヒト型セラミドであり、ヒト型セラミドとは構造が異なる。またヒト型セラミドは、糖やリン酸が結合していない遊離の形(フリーセラミド)をとり、通常の生きた細胞には含まれないことから、自然界にはほとんど存在していない成分となる。そのため、天然物由来のフリーセラミドの開発が求められている。 On the other hand, these glucosylceramides are non-human ceramides and differ in structure from human ceramides. In addition, human ceramide is in a free form (free ceramide) in which sugars and phosphoric acids are not bound, and is not contained in normal living cells, so it is a component that hardly exists in the natural world. Therefore, the development of free ceramides derived from natural products is desired.
 本発明者らは、ポリフェノールとセラミド(特に、フリーセラミド)とを含む、健康および/または美容に有用な新規組成物を見出した。本発明者らはまた、ワイン醸造の際に生成される発酵粕に対して特定の処理を行うことにより、ポリフェノールに加えてセラミド(特に、フリーセラミド)を含む組成物を得ることができることを見出した。したがって、本願発明では、このようなポリフェノールおよびセラミドを含有する天然物由来の組成物や、その製造方法を提供する。 The present inventors have found a novel composition useful for health and/or beauty, containing polyphenols and ceramide (especially free ceramide). The present inventors also found that a composition containing ceramide (particularly, free ceramide) in addition to polyphenols can be obtained by subjecting fermented lees produced during wine brewing to a specific treatment. rice field. Therefore, the present invention provides a composition derived from a natural product containing such polyphenols and ceramides, and a method for producing the same.
 したがって、本発明の主要な観点によれば、以下の発明が提供される。
(項目1)
 ポリフェノールおよびセラミドを含有する美容用および/または経口摂取用組成物。
(項目2)
 前記セラミドが、フリーセラミドおよびグルコシルセラミドを含む、上記項目に記載の組成物。
(項目3)
 前記組成物が、少なくとも約1重量%のフリーセラミドを含む、上記項目のいずれか一項に記載の組成物。
(項目4)
 前記組成物が、少なくとも約1重量%のグルコシルセラミドを含む、上記項目のいずれか一項に記載の組成物。
(項目5)
 前記組成物が、少なくとも約1重量%のポリフェノールを含む、上記項目のいずれか一項に記載の組成物。
(項目6)
 前記組成物におけるフリーセラミド、グルコシルセラミド、及びポリフェノールの重量比が、約0.7~約2.4:約1.0:約1.4~約11.0である、上記項目のいずれか一項に記載の組成物。
(項目7)
 前記組成物におけるフリーセラミド、グルコシルセラミド、及びポリフェノールの重量比が、約1.0:約1.0:約1.0である、上記項目のいずれか一項に記載の組成物。(項目8)
 前記組成物のpHが約5未満である、上記項目のいずれか一項に記載の組成物。
(項目9)
 約100gあたり少なくとも約10mgのレスベラトロールを含む、上記項目のいずれか一項に記載の組成物。
(項目10)
 食品用である、上記項目のいずれか一項に記載の組成物。
(項目11)
 化粧料用である、上記項目のいずれか一項に記載の組成物。
(項目12)
 前記ポリフェノールおよび前記セラミドが、ワイン発酵粕由来である、上記項目のいずれか一項に記載の組成物。
(項目13)
 ケラチノサイトの分化を促進するための、上記項目のいずれか一項に記載の組成物。
(項目14)
 セラミド合成を促進するための、上記項目のいずれか一項に記載の組成物。
(項目A1)
 ワイン発酵粕由来のセラミド含有組成物。
(項目A2)
 前記セラミド含有組成物が、少なくとも約1重量%のフリーセラミドを含む、上記項目のいずれか一項に記載の組成物。
(項目A3)
 前記セラミド含有組成物が、少なくとも約1重量%のグルコシルセラミドを含む、上記項目のいずれか一項に記載の組成物。
(項目A4)
 前記セラミド含有組成物が、少なくとも約1重量%のポリフェノールを含む、上記項目のいずれか一項に記載の組成物。
(項目A5)
 前記組成物におけるフリーセラミド、グルコシルセラミド、及びポリフェノールの重量比が、約0.7~約2.4:約1.0:約1.4~約11.0である、上記項目のいずれか一項に記載の組成物。
(項目A6)
 前記セラミド含有組成物におけるフリーセラミド、グルコシルセラミド、及びポリフェノールの重量比が、約1.0:約1.0:約1.0である、上記項目のいずれか一項に記載の組成物。
(項目A7)
 前記セラミド含有組成物のpHが約5未満である、上記項目のいずれか一項に記載の組成物。
(項目A8)
 約100gあたり少なくとも約10mgのレスベラトロールを含む、上記項目のいずれか一項に記載の組成物。
(項目A9)
 食品用である、上記項目のいずれか一項に記載の組成物。
(項目A10)
 化粧料用である、上記項目のいずれか一項に記載の組成物。
(項目A11)
 ケラチノサイトの分化を促進するための、上記項目のいずれか一項に記載の組成物。
(項目A12)
 セラミド合成を促進するための、上記項目のいずれか一項に記載の組成物。
(項目B1)
 セラミド含有組成物を製造する方法であって、
 ワイン発酵粕を洗浄する工程と、
 該洗浄によって得られた残渣物を極性溶媒で抽出する工程と
を含む、方法。
(項目B2)
 前記極性溶媒がエタノールを含む、上記項目に記載の方法。
(項目B3)
 前記エタノールの濃度が約95%である、上記項目のいずれか一項に記載の方法。
(項目B4)
 前記洗浄する工程が水によって行われる、上記項目のいずれか一項に記載の方法。
(項目B5)
 前記抽出する工程によって得られた抽出物をpH調整する工程をさらに含む、上記項目のいずれか一項に記載の方法。
(項目B6)
 前記pH調整が酒石酸またはクエン酸によって行われる、上記項目のいずれか一項に記載の方法。
(項目C1)
 ケラチノサイトの分化を促進するための方法であって、上記項目のいずれか一項に記載の組成物を投与する工程を含む、方法。
(項目C2)
 セラミド合成を促進するための方法であって、上記項目のいずれか一項に記載の組成物を投与する工程を含む、方法。
Therefore, according to main aspects of the present invention, the following inventions are provided.
(Item 1)
A cosmetic and/or oral composition containing polyphenols and ceramides.
(Item 2)
The composition according to the preceding items, wherein the ceramide comprises free ceramide and glucosylceramide.
(Item 3)
A composition according to any one of the preceding items, wherein the composition comprises at least about 1% by weight of free ceramide.
(Item 4)
A composition according to any one of the preceding items, wherein said composition comprises at least about 1% by weight of glucosylceramide.
(Item 5)
A composition according to any one of the preceding items, wherein the composition comprises at least about 1% by weight of polyphenols.
(Item 6)
Any one of the preceding items, wherein the weight ratio of free ceramide, glucosylceramide, and polyphenol in the composition is about 0.7 to about 2.4: about 1.0: about 1.4 to about 11.0. 13. The composition of claim 1.
(Item 7)
A composition according to any one of the preceding items, wherein the weight ratio of free ceramide, glucosylceramide and polyphenol in the composition is about 1.0: about 1.0: about 1.0. (Item 8)
A composition according to any one of the preceding items, wherein the composition has a pH of less than about 5.
(Item 9)
The composition according to any one of the preceding items, comprising at least about 10 mg resveratrol per about 100 g.
(Item 10)
The composition according to any one of the above items, which is for food.
(Item 11)
The composition according to any one of the above items, which is used for cosmetics.
(Item 12)
The composition according to any one of the above items, wherein the polyphenol and the ceramide are derived from wine fermentation lees.
(Item 13)
A composition according to any one of the preceding items for promoting keratinocyte differentiation.
(Item 14)
A composition according to any one of the preceding items for promoting ceramide synthesis.
(Item A1)
A ceramide-containing composition derived from wine fermentation lees.
(Item A2)
A composition according to any one of the preceding items, wherein the ceramide-containing composition comprises at least about 1% by weight of free ceramide.
(Item A3)
A composition according to any one of the preceding items, wherein the ceramide-containing composition comprises at least about 1% by weight of glucosylceramide.
(Item A4)
A composition according to any one of the preceding items, wherein the ceramide-containing composition comprises at least about 1% by weight of polyphenols.
(Item A5)
Any one of the preceding items, wherein the weight ratio of free ceramide, glucosylceramide, and polyphenol in the composition is about 0.7 to about 2.4: about 1.0: about 1.4 to about 11.0. 13. The composition of claim 1.
(Item A6)
The composition according to any one of the preceding items, wherein the weight ratio of free ceramide, glucosylceramide and polyphenol in the ceramide-containing composition is about 1.0: about 1.0: about 1.0.
(Item A7)
A composition according to any one of the preceding items, wherein the ceramide-containing composition has a pH of less than about 5.
(Item A8)
The composition according to any one of the preceding items, comprising at least about 10 mg resveratrol per about 100 g.
(Item A9)
The composition according to any one of the above items, which is for food.
(Item A10)
The composition according to any one of the above items, which is used for cosmetics.
(Item A11)
A composition according to any one of the preceding items for promoting keratinocyte differentiation.
(Item A12)
A composition according to any one of the preceding items for promoting ceramide synthesis.
(Item B1)
A method for producing a ceramide-containing composition, comprising:
A step of washing the wine fermented lees;
and extracting the residue obtained by said washing with a polar solvent.
(Item B2)
The method according to the preceding items, wherein the polar solvent comprises ethanol.
(Item B3)
A method according to any one of the preceding items, wherein the ethanol concentration is about 95%.
(Item B4)
A method according to any one of the preceding items, wherein the washing step is performed with water.
(Item B5)
A method according to any one of the preceding items, further comprising the step of pH-adjusting the extract obtained by the step of extracting.
(Item B6)
A method according to any one of the preceding items, wherein said pH adjustment is performed with tartaric acid or citric acid.
(Item C1)
A method for promoting keratinocyte differentiation, comprising administering a composition according to any one of the preceding items.
(Item C2)
A method for promoting ceramide synthesis, comprising administering a composition according to any one of the preceding items.
 本開示において、上記の1つまたは複数の特徴は、明示された組み合わせに加え、さらに組み合わせて提供され得ることが意図される。なお、本開示のさらなる実施形態および利点は、必要に応じて以下の詳細な説明を読んで理解すれば、当業者に認識される。 In the present disclosure, it is intended that one or more of the above features may be provided in further combinations in addition to the explicit combinations. Still further embodiments and advantages of the present disclosure will be appreciated by those skilled in the art upon reading and understanding the following detailed description, if necessary.
 なお、上記した以外の本開示の特徴及び顕著な作用・効果は、以下の発明の実施形態の項及び図面を参照することで、当業者にとって明確となる。 It should be noted that features and remarkable actions and effects of the present disclosure other than those described above will become clear to those skilled in the art by referring to the following embodiments of the invention and the drawings.
 本願発明の方法により、ポリフェノールおよびセラミド、特にヒト型のフリーセラミドを含有する組成物を得ることができる。また、ワイン発酵粕からそのような組成物を得る場合には特に、ワイン発酵粕という安全性の高い天然の材料を使用しているため、機能性食品や化粧品などに配合しても、人体に対して悪影響を及ぼすことなく、安全性に優れ、利用価値が高い。 According to the method of the present invention, a composition containing polyphenols and ceramides, especially human-type free ceramides, can be obtained. In particular, when such a composition is obtained from fermented wine lees, it uses fermented wine lees, which is a highly safe natural material. It has excellent safety and high utility value without adversely affecting the environment.
図1は、ワイン澱中のセラミド分子種の組成と大豆中のセラミド分子種の組成との相違を示した一実施形態に係るグラフである。FIG. 1 is a graph according to an embodiment showing the difference between the composition of ceramide molecular species in wine starch and the composition of ceramide molecular species in soybean. 図2は、ワイン澱抽出物から得られたセラミド量とワインから得られたセラミド量との相違を示した一実施形態に係るグラフである。FIG. 2 is a graph according to one embodiment showing the difference between the amount of ceramide obtained from wine lees extract and the amount of ceramide obtained from wine. 図3は、セラミド含有組成物の製法における洗浄工程の検討に用いた、セラミド含有組成物の製法フローを示す模式図である。図3左は原料のワイン澱から95%エタノールでセラミドエキスを抽出した場合、図3右は原料のワイン澱を50%エタノールで洗浄した場合をそれぞれ示す。FIG. 3 is a schematic diagram showing a process flow for producing a ceramide-containing composition, which was used to examine the washing step in the process for producing a ceramide-containing composition. The left side of FIG. 3 shows the case where the ceramide extract was extracted from the starting wine lees with 95% ethanol, and the right side of FIG. 3 shows the case where the starting wine lees were washed with 50% ethanol. 図4は、洗浄工程の相違によるセラミド含有組成物の組成の相違を示す一実施形態に係るグラフである。図4は各成分の含有量(mg)を示している。FIG. 4 is a graph according to one embodiment showing differences in composition of ceramide-containing compositions due to differences in washing processes. FIG. 4 shows the content (mg) of each component. 図5は、洗浄工程の相違(原料のワイン澱から95%エタノールでセラミドエキスを抽出した場合、および原料のワイン澱を50%エタノールで洗浄した場合)によるセラミド含有組成物の組成の相違を示す一実施形態に係るグラフである。図5は各成分の割合を示している。FIG. 5 shows the difference in the composition of the ceramide-containing composition due to the difference in the washing process (when the ceramide extract is extracted from the raw wine lees with 95% ethanol and when the raw wine lees are washed with 50% ethanol). 4 is a graph according to one embodiment; FIG. 5 shows the ratio of each component. 図6は、セラミド含有組成物の製法における洗浄工程の検討に用いた、セラミド含有組成物の製法フローを示す模式図である。原料のワイン澱を水、10%、30%、または50%エタノールで洗浄した場合を示す。FIG. 6 is a schematic diagram showing a process flow for producing a ceramide-containing composition, which was used to examine the washing step in the process for producing a ceramide-containing composition. It shows the case where the raw wine lees are washed with water, 10%, 30%, or 50% ethanol. 図7は、洗浄工程の相違(原料のワイン澱を水、10%、30%、または50%エタノールで洗浄した場合)によるセラミド含有組成物の組成の相違を示す一実施形態に係るグラフである。図7左は各成分の割合を、図7右は各成分の含有量(mg)を、それぞれ示している。FIG. 7 is a graph according to an embodiment showing the difference in the composition of the ceramide-containing composition due to the difference in the washing process (when the raw wine starch was washed with water, 10%, 30%, or 50% ethanol). . The left side of FIG. 7 shows the ratio of each component, and the right side of FIG. 7 shows the content (mg) of each component. 図8は、セラミド含有組成物の製法における洗浄工程の検討に用いた、セラミド含有組成物の製法フローを示す模式図である。原料のワイン澱を40℃または60℃の水で洗浄した場合を示す。FIG. 8 is a schematic diagram showing a process flow for producing a ceramide-containing composition, which was used to examine the washing step in the process for producing a ceramide-containing composition. It shows the case where the raw wine lees are washed with water at 40°C or 60°C. 図9は、洗浄工程の相違(原料のワイン澱を40℃または60℃の水で洗浄した場合)によるセラミド含有組成物の組成の相違を示す一実施形態に係るグラフである。図9左は各成分の割合を、図9右は各成分の含有量(mg)を、それぞれ示している。FIG. 9 is a graph according to one embodiment showing the difference in the composition of the ceramide-containing composition due to the difference in the washing process (when the raw wine starch is washed with water at 40° C. or 60° C.). The left side of FIG. 9 shows the ratio of each component, and the right side of FIG. 9 shows the content (mg) of each component. 図10は、セラミド含有組成物の製法における洗浄工程の検討に用いた、セラミド含有組成物の製法フローを示す模式図である。原料のワイン澱を30、60、または180分にわたって水で洗浄した場合を示す。FIG. 10 is a schematic diagram showing a process flow for producing a ceramide-containing composition, which was used to examine the washing step in the process for producing a ceramide-containing composition. Raw wine lees are shown washed with water for 30, 60, or 180 minutes. 図11は、洗浄工程の相違(原料のワイン澱を30、60、または180分にわたって水で洗浄した場合)によるセラミド含有組成物の組成の相違を示す一実施形態に係るグラフである。図11左は各成分の割合を、図11右は各成分の含有量(mg)を、それぞれ示している。FIG. 11 is a graph according to one embodiment showing the difference in the composition of the ceramide-containing composition due to the difference in the washing process (when the raw wine lees are washed with water for 30, 60, or 180 minutes). The left side of FIG. 11 shows the ratio of each component, and the right side of FIG. 11 shows the content (mg) of each component. 図12は、セラミド含有組成物の製法における洗浄工程の検討に用いた、セラミド含有組成物の製法フローを示す模式図である。原料のワイン澱を10倍、8.3倍、6.7倍の加水量で洗浄した場合を示す。FIG. 12 is a schematic diagram showing a process flow for producing a ceramide-containing composition, which was used to examine the washing step in the process for producing a ceramide-containing composition. It shows the case where the raw material wine sediment was washed with 10 times, 8.3 times, and 6.7 times the amount of water. 図13は、洗浄工程の相違(原料のワイン澱を10倍、8.3倍、6.7倍の加水量で洗浄した場合)によるセラミド含有組成物の組成の相違を示す一実施形態に係るグラフである。図11左は各成分の割合を、図11右は各成分の含有量(mg)を、それぞれ示している。FIG. 13 shows the difference in the composition of the ceramide-containing composition due to the difference in the washing process (when the raw wine starch was washed with 10 times, 8.3 times, and 6.7 times the amount of water) according to one embodiment. graph. The left side of FIG. 11 shows the ratio of each component, and the right side of FIG. 11 shows the content (mg) of each component. 図14は、セラミド含有組成物の製法におけるpH調整の検討に用いた、セラミド含有組成物の製法フローを示す模式図である。原料のワイン澱から抽出されたセラミドエキスに酒石酸、クエン酸、または炭酸ナトリウムを添加した場合を示す。FIG. 14 is a schematic diagram showing a process flow for producing a ceramide-containing composition, which was used to examine pH adjustment in the process for producing a ceramide-containing composition. It shows the case where tartaric acid, citric acid, or sodium carbonate is added to the ceramide extract extracted from the raw wine lees. 図15は、pHの相違によるセラミド含有組成物の色の相違を示す一実施形態に係る写真である。FIG. 15 is a photograph according to one embodiment showing the difference in color of the ceramide-containing composition due to the difference in pH. 図16は、セラミド含有組成物のヒト表皮細胞の増殖への影響を示す一実施形態に係るグラフである。セラミド含有組成物を様々な濃度で添加した培地でヒト表皮細胞(Hacat細胞)を培養すると、無添加の培地に比べて、セラミド含有組成物の処理群では細胞増殖活性が顕著に増加した。FIG. 16 is a graph according to one embodiment showing the effect of a ceramide-containing composition on human epidermal cell proliferation. When human epidermal cells (Hacat cells) were cultured in a medium supplemented with various concentrations of the ceramide-containing composition, cell growth activity was significantly increased in the group treated with the ceramide-containing composition compared to the non-supplemented medium. 図17は、赤ワイン、ワイン澱(ワインクリスタル)、セラミド含有組成物(ワインセラミド)に含まれるレスベラトロールの量を示す一実施形態に係るグラフである。FIG. 17 is a graph according to one embodiment showing the amount of resveratrol contained in red wine, wine lees (wine crystals), and ceramide-containing composition (wine ceramide). 図18は、本願発明の一実施形態に係るワインセラミドをヒト表皮ケラチノサイトHacat細胞株に添加し、72時間培養した場合の分化マーカー(Pro-FilaggrinおよびLoricrin)のmRNA発現量を示すグラフである。FIG. 18 is a graph showing mRNA expression levels of differentiation markers (Pro-Filaggrin and Loricrin) when wine ceramide according to one embodiment of the present invention was added to a human epidermal keratinocyte Hacat cell line and cultured for 72 hours. 図19は、本願発明の一実施形態に係るワインセラミドをヒト表皮ケラチノサイトHacat細胞株に添加し、72時間培養した場合のセラミド合成経路マーカー(SPT:Serine-Palmitoyl Transferase)のmRNA発現量を示すグラフである。FIG. 19 is a graph showing the mRNA expression level of ceramide synthesis pathway marker (SPT: Serine-Palmitoyl Transferase) when wine ceramide according to one embodiment of the present invention was added to human epidermal keratinocyte Hacat cell line and cultured for 72 hours. is. 図20は、本願発明の一実施形態に係るワインセラミド、グルコシルセラミド、およびフリーセラミドをヒト表皮ケラチノサイトHacat細胞株に添加し、72時間培養した場合の分化マーカー(Pro-Filaggrin)、およびセラミド合成経路マーカー(SPT)のmRNA発現量を示すグラフである。FIG. 20 shows a differentiation marker (Pro-Filaggrin) and ceramide synthesis pathway when wine ceramide, glucosylceramide, and free ceramide according to one embodiment of the present invention were added to human epidermal keratinocyte Hacat cell line and cultured for 72 hours. It is a graph which shows the mRNA expression level of a marker (SPT). 図21は、本願発明の一実施形態に係るワインセラミド、およびワイン以外の原料から得られた各セラミド(米セラミド、パインセラミド、およびこんにゃくセラミド)をヒト表皮ケラチノサイトHacat細胞株に添加し、72時間培養した場合の分化マーカー(Pro-Filaggrin)、およびセラミド合成経路マーカー(SPT)のmRNA発現量を示すグラフである。FIG. 21 shows that wine ceramide according to one embodiment of the present invention and ceramides obtained from raw materials other than wine (rice ceramide, pine ceramide, and konjac ceramide) were added to human epidermal keratinocyte Hacat cell line, and 72 hours. 1 is a graph showing mRNA expression levels of a differentiation marker (Pro-Filaggrin) and a ceramide synthesis pathway marker (SPT) when cultured. 図22は、本願発明の一実施形態に係るワインセラミドを3D培養したケラチノサイトに添加して48時間培養した場合の細胞切片写真である。細胞切片のセラミド量をヘマトキシリン・エオシン染色して位相差顕微鏡下で観察した。グラフは、皮膚の厚みの平均値±SD値をμm単位で示している(N=4)。本願発明の一実施形態に係るワインセラミドは、表皮の厚さを有意に増加させた。FIG. 22 is a photograph of a cell section when wine ceramide according to one embodiment of the present invention was added to 3D-cultured keratinocytes and cultured for 48 hours. The amount of ceramide in the cell section was stained with hematoxylin and eosin and observed under a phase-contrast microscope. The graph shows mean ± SD values of skin thickness in μm (N=4). Wine ceramide according to one embodiment of the present invention significantly increased epidermal thickness. 図23は、本願発明の一実施形態に係るワインセラミドを3D培養したケラチノサイトに添加して48時間培養した場合の細胞切片写真である。細胞切片のセラミド量を抗セラミド抗体で免疫染色して位相差顕微鏡下で観察した。グラフは、3D培養したケラチノサイトにおける相対蛍光密度の平均値±SD値を示す(N=4)。本願発明の一実施形態に係るワインセラミドは、皮膚のセラミド量を有意に増加させた。FIG. 23 is a photograph of a cell section when wine ceramide according to one embodiment of the present invention was added to 3D-cultured keratinocytes and cultured for 48 hours. The amount of ceramide in the cell section was immunostained with an anti-ceramide antibody and observed under a phase-contrast microscope. The graph shows the mean±SD value of relative fluorescence density in 3D cultured keratinocytes (N=4). Wine ceramide according to one embodiment of the present invention significantly increased the amount of ceramide in the skin.
 以下、本開示を最良の形態を示しながら説明する。本明細書の全体にわたり、単数形の表現は、特に言及しない限り、その複数形の概念をも含むことが理解されるべきである。従って、単数形の冠詞(例えば、英語の場合は「a」、「an」、「the」など)は、特に言及しない限り、その複数形の概念をも含むことが理解されるべきである。また、本明細書において使用される用語は、特に言及しない限り、当該分野で通常用いられる意味で用いられることが理解されるべきである。したがって、他に定義されない限り、本明細書中で使用される全ての専門用語および科学技術用語は、本開示の属する分野の当業者によって一般的に理解されるのと同じ意味を有する。矛盾する場合、本明細書(定義を含めて)が優先する。 The present disclosure will be described below while showing the best mode. It should be understood that throughout this specification, expressions in the singular also include the concept of the plural unless specifically stated otherwise. Thus, articles in the singular (eg, “a,” “an,” “the,” etc. in the English language) should be understood to include their plural forms as well, unless otherwise stated. Also, it should be understood that the terms used in this specification have the meanings commonly used in the relevant field unless otherwise specified. Thus, unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this disclosure belongs. In case of conflict, the present specification (including definitions) will control.
 以下に本明細書において特に使用される用語の定義および/または基本的技術内容を適宜説明する。 Definitions of terms and/or basic technical contents particularly used in this specification are explained below as appropriate.
 本明細書において、「約」とは、後に続く数値の±10%を意味する。 As used herein, "about" means ±10% of the following numerical value.
 本明細書において、「セラミド」とは、スフィンゴ脂質の一種であり、スフィンゴシンと脂肪酸がアミド結合した化合物群をいう。本明細書において、「セラミド」には、セラミドの誘導体も含まれる。セラミドはスフィンゴイド塩基のアミノ基(-NH)に脂肪酸のカルボキシル基(-COOH)が結合した構造(-NH-CO-)を有する化合物である。セラミドのスフィンゴイド塩基のアルコール性ヒドロキシル基(-OH)に、さらに糖及びリン酸などの極性基が結合し、それぞれスフィンゴ糖脂質及びスフィンゴリン脂質となる。ここで、糖が結合したものを特にグリコシルセラミドと呼び、特に糖がグルコースである場合、グルコシルセラミドと呼ぶ。セラミドに糖やリン酸などが結合していない場合にフリーセラミドと呼ぶ。フリーセラミドは一般にはスフィンゴ脂質合成系の中間代謝物であるため、特に動物及び植物においては、微量しか存在しない。ガラクトシルセラミド、グルコシルセラミド、およびスフィンゴミエリンなどのように、セラミドに糖やリン酸が結合したものは、動植物から抽出されるものの、糖やリン酸が結合しているために、細胞間脂質中での配向性がフリーセラミドとは異なる。 As used herein, “ceramide” is a kind of sphingolipid and refers to a group of compounds in which sphingosine and fatty acid are amide bonded. As used herein, "ceramide" also includes ceramide derivatives. Ceramide is a compound having a structure (--NH--CO--) in which an amino group (--NH 2 ) of a sphingoid base is bonded to a carboxyl group (--COOH) of a fatty acid. The alcoholic hydroxyl group (--OH) of the sphingoid base of ceramide is further combined with a polar group such as sugar and phosphoric acid to form glycosphingolipids and phosphosphingolipids, respectively. Here, those bound with sugars are particularly called glycosylceramides, and particularly when the sugar is glucose, they are called glucosylceramides. Ceramide is called free ceramide when sugar, phosphoric acid, etc. are not bound to ceramide. Since free ceramide is generally an intermediate metabolite in the sphingolipid synthesis system, it exists only in minute amounts, especially in animals and plants. Galactosylceramide, glucosylceramide, and sphingomyelin, in which ceramide is bound with sugar or phosphoric acid, are extracted from animals and plants, but because the sugar or phosphoric acid is bound, they are not found in intercellular lipids. orientation is different from that of free ceramide.
 本明細書において、「ポリフェノール」とは、分子内に複数のフェノール性水酸基を有する化合物の総称をいい、具体的には、フラボノール、フラボン、イソフラボン、タンニン、カテキン、ケルセチン、アントシアニン、アントシアニジン、ロイコアントシアニジン、プロアントシアニジン、没食子酸プロピル、カテキン、ルチン、ケルセチン、フェルラ酸、レスベラトロール、プロシアニジン、テアフラビン、クルクミン、ピクノジェノール、ロズマリン酸、エラグ酸、キナ酸、クロロゲン酸、ヒドロキシチロソール等が挙げられる。 As used herein, "polyphenol" is a general term for compounds having multiple phenolic hydroxyl groups in the molecule, specifically flavonols, flavones, isoflavones, tannins, catechins, quercetin, anthocyanins, anthocyanidins, leucoanthocyanidins. , proanthocyanidins, propyl gallate, catechin, rutin, quercetin, ferulic acid, resveratrol, procyanidins, theaflavin, curcumin, pycnogenol, rosmarinic acid, ellagic acid, quinic acid, chlorogenic acid, hydroxytyrosol and the like.
 本明細書において、「洗浄」とは、ワイン発酵粕(ワイン澱)と液体を攪拌しながら混合して不純物を洗い流して除去することをいう。 As used herein, "washing" refers to washing away and removing impurities by stirring and mixing wine fermented lees (wine lees) and liquid.
 本明細書において、「抽出」とは、溶液に含まれる分析対象物とそれ以外の不純物とを分離することを意味し、溶媒抽出または液液抽出ともいう。 As used herein, "extraction" means separating the analyte contained in the solution from other impurities, and is also referred to as solvent extraction or liquid-liquid extraction.
 (好ましい実施形態)
 以下に本開示の好ましい実施形態を説明する。以下に提供される実施形態は、本開示のよりよい理解のために提供されるものであり、本開示の範囲は以下の記載に限定されるべきでない。したがって、当業者は、本明細書中の記載を参酌して、本開示の範囲内で適宜改変を行うことができることは明らかである。また、本開示の以下の実施形態は単独でも使用されあるいはそれらを組み合わせて使用することができる。
(preferred embodiment)
Preferred embodiments of the present disclosure are described below. The embodiments provided below are provided for better understanding of the present disclosure, and the scope of the present disclosure should not be limited to the following description. Therefore, it is clear that a person skilled in the art can make appropriate modifications within the scope of the present disclosure in light of the description in this specification. Also, the following embodiments of the disclosure may be used singly or in combination.
 本願発明の一局面において、ポリフェノールおよびセラミドを含有する美容用および/または経口摂取用組成物が提供される。また本開示の他の局面において、ワイン発酵粕由来のセラミド含有組成物が提供される。ポリフェノールおよびセラミドを含有する美容用および/または経口摂取用組成物、並びにワイン発酵粕由来のセラミド含有組成物は、ともにセラミドを含有するものであるため、本明細書においては、特に言及する場合を除いて、まとめて「セラミド含有組成物」ということができる。また本明細書において、本願発明のセラミド含有組成物を「ワインセラミド」と呼ぶ場合がある。 In one aspect of the present invention, a cosmetic and/or oral composition containing polyphenols and ceramides is provided. In another aspect of the present disclosure, a ceramide-containing composition derived from wine fermentation lees is provided. Since both the cosmetic and/or oral intake composition containing polyphenol and ceramide and the ceramide-containing composition derived from fermented wine lees contain ceramide, they are not particularly mentioned in the present specification. Except for this, it can be collectively referred to as a "ceramide-containing composition". Moreover, in this specification, the ceramide-containing composition of the present invention may be referred to as "wine ceramide".
 セラミドは、スフィンゴ脂質の一種であり、スフィンゴシンと脂肪酸がアミド結合した化合物群を含む。またセラミドは、分子中に1個以上の長鎖の直鎖および/もしくは分岐アルキルまたはアルケニル基、さらに、少なくとも2個以上の水酸基、1個以上のアミド基(および/またはアミノ基)を有する非イオン系両親媒性物質であってもよい。また、セラミドは、前記非イオン系両親媒性物質の水酸基にフォスファチジルコリン残基、または糖残基が結合した物質(いわゆるセラミド誘導体の一種)であってもよい。 Ceramide is a type of sphingolipid and includes a group of compounds in which sphingosine and fatty acid are amide bonded. In addition, ceramide is a non-permeable compound having one or more long-chain straight and/or branched alkyl or alkenyl groups, at least two hydroxyl groups, and one or more amide groups (and/or amino groups) in the molecule. It may be an ionic amphiphilic substance. Ceramide may also be a substance in which a phosphatidylcholine residue or a sugar residue is bound to the hydroxyl group of the nonionic amphiphilic substance (a type of so-called ceramide derivative).
 一実施形態において、セラミドには、フリーセラミドおよびグルコシルセラミドが含まれる。例えば、好ましい一実施態様において、セラミドとしては、植物由来のセラミドが含まれ、好ましくはワイン発酵粕由来のセラミドを含む。 In one embodiment, ceramides include free ceramides and glucosylceramides. For example, in a preferred embodiment, ceramides include plant-derived ceramides, preferably wine fermentation lees-derived ceramides.
 フリーセラミドとしては、化粧品や皮膚外用剤、または食品用に用いることができるものであれば特に限定されず、セラミド1、セラミド2、セラミド3、セラミド3B、セラミド4、セラミド5、セラミド6、セラミド6I、およびセラミド6IIなどの天然フリーセラミドを挙げることができる。本願発明のセラミド含有組成物は、その取得に際し、人体に対して悪影響を及ぼすことのない材料を用いて取得することが可能であるため、食品用や皮膚塗布用を始めとして、安全性が重要視される用途の原料として有効である。またヒト型のフリーセラミドを含むため、健康食品などの食品用原料としても適している。本開示の一実施形態において、本願発明のセラミド含有組成物は、これらのフリーセラミドの1種のみ、または2種以上の任意の混合比の組み合わせを含むことができる。 The free ceramide is not particularly limited as long as it can be used for cosmetics, external skin preparations, or food. 6I, and natural free ceramides such as ceramide 6II. The ceramide-containing composition of the present invention can be obtained using materials that do not adversely affect the human body, so safety is important for food and skin applications. It is effective as a raw material for the intended use. In addition, since it contains human-type free ceramide, it is also suitable as a raw material for foods such as health foods. In one embodiment of the present disclosure, the ceramide-containing composition of the present invention can contain only one type of these free ceramides or a combination of two or more types in any mixing ratio.
 本願発明のセラミド含有組成物におけるセラミドは皮膚の水分を蒸散させないバリア機能、バリア機能を回復する機能、毛髪にハリやコシを付与する機能、角質剥離作用促進し、皮膚を滑らかにする機能、皮膚や毛髪に適用された場合に保湿効果を発揮する機能、セラミド産生促進効果を発揮する機能など種々の機能を有するが、本願発明のセラミド含有組成物の機能はこれらの機能のうちの1つもしくは2つ以上に限定されるものではなく、これら機能以外のセラミドとしての機能を有していてもよい。 The ceramide in the ceramide-containing composition of the present invention has a barrier function that prevents moisture from evaporating from the skin, a function that restores the barrier function, a function that imparts firmness and elasticity to the hair, a function that promotes exfoliation of keratin, a function that smoothes the skin, and a skin The ceramide-containing composition of the present invention has various functions such as a function of exerting a moisturizing effect when applied to hair and a function of exerting a ceramide production promoting effect, and the function of the ceramide-containing composition of the present invention is one of these functions or It is not limited to two or more, and may have a function as a ceramide other than these functions.
 本願発明の一実施形態において、本願発明のセラミド含有組成物は、皮膚に適用しても良いし、食用として用いることもできる。いずれの場合にも肌の保湿や、シミしわ改善、紫外線対策などを含む上記機能を享受することができる。 In one embodiment of the present invention, the ceramide-containing composition of the present invention may be applied to the skin or used as food. In either case, it is possible to enjoy the above-mentioned functions including moisturizing of the skin, improvement of dark spots and wrinkles, protection against ultraviolet rays, and the like.
 本願発明の一実施形態において、本願発明のセラミド含有組成物は、皮膚に適用し、および/または食品として摂取することにより、皮膚におけるケラチノサイトの分化を促進し、および/またはセラミドのDe novo合成を促進することができる。本願発明のセラミド含有組成物は、例えば、ケラチノサイトの分化マーカーの遺伝子発現を増加させることができる。ケラチノサイトの分化マーカーとしては、ケラチノサイトの分化を確認できるものであれば特に限られないが、好ましくは遺伝子マーカーを挙げることができ、例えば、Pro-Filaggrin(肌の角質層を形成するタンパク質。天然保湿因子(NMF)の原料)やLoricrin(角質層を正常に形成するための骨組みとなるタンパク質)などを挙げることができる。 In one embodiment of the present invention, the ceramide-containing composition of the present invention promotes differentiation of keratinocytes in the skin and/or promotes de novo synthesis of ceramide by being applied to the skin and/or ingested as food. can be promoted. The ceramide-containing composition of the present invention can, for example, increase gene expression of keratinocyte differentiation markers. The keratinocyte differentiation marker is not particularly limited as long as it can confirm keratinocyte differentiation, but preferably includes a genetic marker. factor (NMF)) and Loricrin (a protein that serves as a framework for normal formation of the stratum corneum).
 また本願発明のセラミド含有組成物は、例えば、セラミドの合成経路におけるセラミド合成に関連する遺伝子の発現を増強させることにより、セラミドの合成を促進することができる。セラミドのDe novo合成は、Serine+Palmitoyl CoA
 → 3-keto-sphinganine → Sphinganine → Dihydroceramide → Ceramideという経路が知られている。セラミド合成経路の分化マーカーとしては、セラミドの合成経路に関与するものであれば特に限られないが、好ましくは遺伝子マーカーを挙げることができ、例えば、SPT:Serine-Palmitoyl Transferase(セラミド de novo合成経路の酵素)などを挙げることができる。SPTは、上記セラミド合成経路におけるSerine+Palmitoyl CoAから3-keto-sphinganineへの変換を触媒する。
In addition, the ceramide-containing composition of the present invention can promote ceramide synthesis, for example, by enhancing the expression of genes associated with ceramide synthesis in the ceramide synthesis pathway. De novo synthesis of ceramide is based on Serine + Palmitoyl CoA
→ 3-keto-sphinganine → Sphinganine → Dihydroceramide → Ceramide is known. The differentiation marker of the ceramide synthesis pathway is not particularly limited as long as it is involved in the ceramide synthesis pathway, but preferably includes a genetic marker. (enzyme). SPT catalyzes the conversion of Serine+Palmitoyl CoA to 3-keto-sphinganine in the ceramide synthesis pathway.
 また本願発明のセラミド含有組成物は、ケラチノサイトの増加および分化を促進することで、皮膚の厚さを増加させ、皮膚のターンオーバーも促進させることができる。 In addition, the ceramide-containing composition of the present invention can increase skin thickness and promote skin turnover by promoting the increase and differentiation of keratinocytes.
 本願発明の一実施形態において、本願発明のセラミド含有組成物は、少なくとも約0.01重量%以上のフリーセラミドを含み、好ましくは少なくとも約0.1重量%以上、少なくとも約0.3重量%以上、少なくとも約0.5重量%以上、または少なくとも約0.8重量%以上のフリーセラミドを含むことができ、さらに好ましくは少なくとも約1重量%以上のフリーセラミドを含むことができる。 In one embodiment of the present invention, the ceramide-containing composition of the present invention comprises at least about 0.01 wt% or more free ceramide, preferably at least about 0.1 wt% or more, at least about 0.3 wt% or more. , at least about 0.5% by weight or more, or at least about 0.8% by weight or more of free ceramide, and more preferably at least about 1% by weight or more of free ceramide.
 本願発明の一実施形態において、本願発明のセラミド含有組成物は、少なくとも約0.01重量%以上のグルコシルセラミドを含み、好ましくは少なくとも約0.1重量%以上、少なくとも約0.3重量%以上、少なくとも約0.5重量%以上、または少なくとも約0.8重量%以上のグルコシルセラミドを含むことができ、さらに好ましくは少なくとも約1重量%以上のグルコシルセラミドを含むことができる。 In one embodiment of the present invention, the ceramide-containing composition of the present invention comprises at least about 0.01 wt% or more of glucosylceramide, preferably at least about 0.1 wt% or more, at least about 0.3 wt% or more. , at least about 0.5% by weight or more, or at least about 0.8% by weight or more of glucosylceramide, and more preferably at least about 1% by weight or more of glucosylceramide.
 ポリフェノールは、分子内に複数のフェノール性水酸基を有する化合物であり、本願発明の組成物に含まれるポリフェノールの種類については、特に制限されないが、例えば、フラボノール、フラボン、イソフラボン、タンニン、カテキン、ケルセチン、アントシアニン、アントシアニジン、ロイコアントシアニジン、プロアントシアニジン、没食子酸プロピル、カテキン、ルチン、ケルセチン、フェルラ酸、レスベラトロール、プロシアニジン、テアフラビン、クルクミン、ピクノジェノール、ロズマリン酸、エラグ酸、キナ酸、クロロゲン酸、ヒドロキシチロソール等が挙げられる。本願発明の組成物においては、これらのポリフェノールが1種単独で含まれていてもよく、また2種以上が組み合わせて含まれていてもよい。 Polyphenol is a compound having a plurality of phenolic hydroxyl groups in the molecule, and the type of polyphenol contained in the composition of the present invention is not particularly limited. Examples include flavonol, flavone, isoflavone, tannin, catechin, quercetin, Anthocyanin, anthocyanidin, leucoanthocyanidin, proanthocyanidin, propyl gallate, catechin, rutin, quercetin, ferulic acid, resveratrol, procyanidin, theaflavin, curcumin, pycnogenol, rosmarinic acid, ellagic acid, quinic acid, chlorogenic acid, hydroxytyrosol etc. In the composition of the present invention, these polyphenols may be contained singly or in combination of two or more.
 一実施形態において、本願発明の組成物におけるポリフェノールの含有量は、少なくとも約0.01重量%以上であり、好ましくは少なくとも約0.1重量%以上、少なくとも約0.3重量%以上、少なくとも約0.5重量%以上、または少なくとも約0.8重量%以上であり、さらに好ましくは少なくとも約1重量%以上とすることができる。 In one embodiment, the polyphenol content in the compositions of the present invention is at least about 0.01 wt% or more, preferably at least about 0.1 wt% or more, at least about 0.3 wt% or more, at least about It can be at least 0.5% by weight, or at least about 0.8% by weight or more, and more preferably at least about 1% by weight or more.
 本願発明の一実施形態において、本願発明の組成物は、ポリフェノールとしてレスベラトロールを含むことができ、約100gの本願発明の組成物あたり少なくとも約1mg、少なくとも約3mg、少なくとも約5mg、少なくとも約7mg、または少なくとも約10mgのレスベラトロールを含むことができる。 In one embodiment of the present invention, the composition of the present invention may comprise resveratrol as a polyphenol in an amount of at least about 1 mg, at least about 3 mg, at least about 5 mg, at least about 7 mg per about 100 g of the composition of the present invention. , or at least about 10 mg resveratrol.
 本願発明の一実施形態において、本願発明の組成物は、上記のようなグルコシルセラミド、フリーセラミド、及びポリフェノールを、その重量比で、グルコシルセラミド:フリーセラミド:ポリフェノール=約1.0:約0.5~約3.0:約1.0~約15.0、好ましくは約1.0:約0.7~約2.4:約1.4~約11.0、さらに好ましくは約約1.0:約1.0:約1.0とすることができる。食品原料としてのセラミドについては、コンニャクやコメなど多くの植物由来のセラミドが製造されているが、いずれもグルコシルセラミドを主成分としているため、本願発明のセラミド含有組成物は、グルコシルセラミドと同程度に、またはそれ以上にフリーセラミドを含む点で有用である。 In one embodiment of the present invention, the composition of the present invention contains glucosylceramide, free ceramide, and polyphenol as described above in a weight ratio of glucosylceramide:free ceramide:polyphenol=about 1.0:about 0.5. 5 to about 3.0: about 1.0 to about 15.0, preferably about 1.0: about 0.7 to about 2.4: about 1.4 to about 11.0, more preferably about 1 .0: about 1.0: about 1.0. Regarding ceramide as a food raw material, many plant-derived ceramides such as konjac and rice are produced, but since all of them contain glucosylceramide as the main component, the ceramide-containing composition of the present invention has the same level of glucosylceramide. It is useful in that it contains less or more free ceramide.
 他の実施形態において、本願発明の組成物は、セラミド及びポリフェノールを、その重量比で、総セラミド:ポリフェノール=約1.0:約0.5~約5.0、好ましくは約1.0:約0.7~約4.0とすることができる。 In another embodiment, the compositions of the present invention contain ceramides and polyphenols in a weight ratio of total ceramides: polyphenols of about 1.0: about 0.5 to about 5.0, preferably about 1.0: It can be from about 0.7 to about 4.0.
 本願発明の他の局面において、セラミド含有組成物を製造する方法であって、ワイン発酵粕を洗浄する工程と、該洗浄によって得られた残渣物を極性溶媒で抽出する工程とを含む、方法が提供される。 In another aspect of the present invention, a method for producing a ceramide-containing composition, comprising the steps of washing wine fermented lees and extracting the residue obtained by the washing with a polar solvent. provided.
 本願発明のセラミド含有組成物の製造方法は、ワイン醸造の際に得られるワイン発酵粕(澱)(Bitartrate)を洗浄し、その後、残渣物を極性溶媒で抽出し発酵物抽出液を得ることを特徴とする。ワイン発酵粕の原料となるブドウ品種や酵母の種類やワインの製法は特に限定されず、どのようなブドウ品種や製法を用いた場合でも、例えばワイン樽の底や壁面にたまる澱を本願発明のワイン発酵粕として利用することができる。ワイン発酵の際に使用するワイン酵母は特に限定されないが、自然酵母や培養酵母を利用することができる。したがって、どのような種類のワイン澱を出発原料としても、本願発明のセラミド含有組成物の製造方法により、セラミドやグルコシルセラミドの含量を高めた組成物をセルことができる。 The method for producing a ceramide-containing composition of the present invention comprises washing wine fermentation lees (bitartrate) obtained during wine brewing, and then extracting the residue with a polar solvent to obtain a fermented product extract. Characterized by There are no particular restrictions on the grape variety, the type of yeast, or the wine production method used as the raw material for the wine fermented lees. It can be used as wine fermentation lees. Wine yeast used for wine fermentation is not particularly limited, but natural yeast and cultured yeast can be used. Therefore, no matter what type of wine lees is used as a starting material, a composition with an increased content of ceramide or glucosylceramide can be produced by the method for producing a ceramide-containing composition of the present invention.
 一実施形態において、極性溶媒としては、水、メタノール、エタノール、イソプロピルアルコール、1,3-ブチレングリコール、エチレングリコール、プロピレングリコール、グリセリン、酢酸エチル等の極性溶媒を使用することができる。これらの溶媒を2種以上混合してもよい。好ましくは、極性溶媒として、エタノール、またはエタノールと水の混合物である含水エタノールを用いると、本願発明のセラミド含有組成物を効率よく抽出することができる。 In one embodiment, polar solvents such as water, methanol, ethanol, isopropyl alcohol, 1,3-butylene glycol, ethylene glycol, propylene glycol, glycerin, and ethyl acetate can be used as polar solvents. Two or more of these solvents may be mixed. Preferably, the ceramide-containing composition of the present invention can be efficiently extracted by using ethanol or hydrous ethanol, which is a mixture of ethanol and water, as the polar solvent.
 極性溶媒としての含水エタノールを用いる場合、エタノールの濃度は特に限定されず、例えばエタノール濃度を約10%~約99%(wt/wt)とすることができ、好ましくはエタノール濃度を、少なくとも約70%以上、約75%以上、約80%以上、約85%以上、約90%以上、約93%以上、約95%以上、約98%以上、約99%以上(wt/wt)とすることができる。 When hydrous ethanol is used as the polar solvent, the concentration of ethanol is not particularly limited, for example, the ethanol concentration can be about 10% to about 99% (wt/wt), preferably the ethanol concentration is at least about 70%. % or more, about 75% or more, about 80% or more, about 85% or more, about 90% or more, about 93% or more, about 95% or more, about 98% or more, about 99% or more (wt/wt) can be done.
 一実施形態において、抽出工程における抽出温度としては、約30℃~約80℃、好ましくは約40℃~約60℃で行うことができる。また抽出時間としては、約1時間~約8時間、好ましくは、約3時間~約6時間とすることができる。 In one embodiment, the extraction temperature in the extraction step is about 30°C to about 80°C, preferably about 40°C to about 60°C. The extraction time can be about 1 hour to about 8 hours, preferably about 3 hours to about 6 hours.
 抽出方法としては、撹拌抽出、連続抽出、浸漬抽出、向流抽出、超臨界抽出など任意の方法を採用することができ、室温ないし還流加熱下において任意の装置を使用することができる。好ましくは、本願発明の方法において、抽出方法としてはオール型やプロペラ型の撹拌機を用いて攪拌抽出を行うことができる。一実施形態において、攪拌抽出を行う場合には、所定の温度に加温しながら抽出タンク内でワイン澱と溶媒(エタノールなど)を攪拌させて抽出することができる。所定の時間にわたって攪拌した後、ろ過し、ろ液をセラミド画分(本願発明のセラミド含有組成物)とすることができる。抽出の規模は適宜設定することができ、そのため、他の実施形態において、ウォーターバス内にビーカーを設置し、そのビーカー内で、ワイン澱と溶媒(エタノールなど)を攪拌させて抽出することもできる。 Any method such as stirring extraction, continuous extraction, immersion extraction, countercurrent extraction, or supercritical extraction can be used as the extraction method, and any device can be used at room temperature or under reflux heating. Preferably, in the method of the present invention, stirring extraction can be performed using an oar-type or propeller-type stirrer as the extraction method. In one embodiment, when stirring extraction is performed, wine lees and a solvent (such as ethanol) can be stirred and extracted in an extraction tank while being heated to a predetermined temperature. After stirring for a predetermined period of time, the mixture is filtered, and the filtrate can be used as a ceramide fraction (the ceramide-containing composition of the present invention). The scale of extraction can be set appropriately, so in another embodiment, a beaker is placed in a water bath, and wine lees and a solvent (such as ethanol) are stirred in the beaker for extraction. .
 一実施形態において、洗浄工程では、ワイン発酵粕(ワイン澱)を水で洗浄することができる。一実施形態において、洗浄工程では、オール型やプロペラ型の撹拌機を用いてワイン発酵粕と水を攪拌しながら洗浄することができる。一実施形態において、ワイン発酵粕と水を混合する際に加温しながら攪拌することもできる。所定の時間にわたって攪拌した後、ろ過し、残渣を抽出工程で用いることができる。水としては、例えば精製水、滅菌水、水道水等が挙げられるが、不純物が少ない点で精製水又は滅菌水が好ましい。この場合、洗浄温度としては、約30℃~約80℃、好ましくは約40℃~約60℃で行うことができる。また洗浄時間としては、約5分~約6時間、好ましくは、約1時間~約2時間とすることができる。 In one embodiment, the wine fermentation lees (wine lees) can be washed with water in the washing step. In one embodiment, in the washing step, washing can be performed while stirring the fermented wine lees and water using an oar-type or propeller-type agitator. In one embodiment, the fermented wine lees and water can be stirred while being heated. After stirring for a period of time, it can be filtered and the residue used in the extraction process. Examples of water include purified water, sterilized water, and tap water. Purified water or sterilized water is preferable because it contains few impurities. In this case, the washing temperature can be about 30°C to about 80°C, preferably about 40°C to about 60°C. The cleaning time can be about 5 minutes to about 6 hours, preferably about 1 hour to about 2 hours.
 本願発明の一実施形態において、本願発明のセラミド含有組成物を製造する方法は、さらに、極性溶媒による抽出工程によって得られた抽出物をpH調整することもできる。このようなpH調整によって、得られたセラミド含有組成物の色彩を調整することができ、好ましくは所望のワイン色にすることもできる。このようなpH調整は酸やアルカリによって行うことができ、酸やアルカリの種類は、本願発明のセラミド含有組成物の効果を損なわない範囲において、また化粧品、飲食品、健康食品、機能性表示食品、特定保健用食品、サプリメント、医薬品、医薬部外品、または皮膚外用剤などに用いられるものであれば特に限られないが、例えば、リン酸、酒石酸、クエン酸、または炭酸ナトリウムなどによって行うことができる。 In one embodiment of the present invention, the method for producing the ceramide-containing composition of the present invention can further adjust the pH of the extract obtained by the extraction step with a polar solvent. By such pH adjustment, the color of the obtained ceramide-containing composition can be adjusted, and preferably a desired wine color can be obtained. Such pH adjustment can be performed with an acid or alkali, and the type of acid or alkali is selected within a range that does not impair the effects of the ceramide-containing composition of the present invention. , food for specified health use, supplements, pharmaceuticals, quasi-drugs, or external skin preparations, but not limited to, for example, phosphoric acid, tartaric acid, citric acid, or sodium carbonate can be done.
 一実施形態において、本願発明のセラミド含有組成物は、所望の用途に応じた色となるようにpH調整することができ、上記のようなpH調整によってセラミド含有組成物のpHを例えば約5未満、約4.8未満、約4.0未満、または約3.5未満とすることができる。 In one embodiment, the ceramide-containing compositions of the present invention can be pH-adjusted for color depending on the desired application, wherein the pH-adjustment as described above reduces the pH of the ceramide-containing composition to, for example, less than about 5. , less than about 4.8, less than about 4.0, or less than about 3.5.
 その他、本願発明のセラミド含有組成物の抽出分離、精製、同定などは通常の操作を幅広く適用することができ、例えば、上記のような抽出工程によって得られたセラミド含有組成物を必要に応じてpH調整し、さらに必要に応じて所望の賦形剤と混合し、濃縮、加熱殺菌、凍結乾燥などを行うこともできる。 In addition, for the extraction, separation, purification, identification, etc. of the ceramide-containing composition of the present invention, a wide range of normal operations can be applied. It is also possible to adjust the pH, mix with desired excipients as necessary, and perform concentration, heat sterilization, freeze-drying, and the like.
 本願発明の1つの好ましい態様において、本願発明のセラミド含有組成物は、ワイン発
酵粕(ワイン澱)を好ましくは約10倍量の約60℃の水で約1時間洗浄し、その後、残渣物を好ましくは約95%のエタノール溶液を用いて約40℃で約6時間にわたって抽出を行うことによって得ることができる。また本願発明の1つの好ましい態様において、本
願発明のセラミド含有組成物は、上記のようにして得た抽出物を、pH約4.0未満に調整することができる。さらに本願発明の1つの好ましい態様において、本願発明のセラミ
ド含有組成物は、シクロデキストリンなどの賦形剤と混合し、さらにエタノールを水に置換することにより濃縮し、約120℃で加熱殺菌し、凍結乾燥して粉末状にすることができる。
In one preferred embodiment of the present invention, the ceramide-containing composition of the present invention is obtained by washing wine fermented lees (wine lees) with preferably about 10 times the amount of water at about 60°C for about 1 hour, and then removing the residue. Preferably, it can be obtained by performing extraction with an ethanol solution of about 95% at about 40° C. for about 6 hours. Further, in one preferred embodiment of the present invention, the ceramide-containing composition of the present invention can adjust the pH of the extract obtained as described above to less than about 4.0. Furthermore, in one preferred embodiment of the present invention, the ceramide-containing composition of the present invention is mixed with an excipient such as cyclodextrin, further concentrated by replacing ethanol with water, heat sterilized at about 120 ° C., It can be lyophilized and powdered.
 本願発明の1つの好ましい態様において、本願発明のセラミド含有組成物は、上記のよ
うな製法で得ることにより、グルコシルセラミド、フリーセラミド、及びポリフェノールを、その重量比で、約1.0:約1.0:約1.0の割合で含むことができる。また本願発明の1つの好ましい態様において、本願発明のセラミド含有組成物は、上記のような製
法で得ることにより、約100gの本願発明の組成物あたり少なくとも約10mgのレスベラトロールを含むことができる。
In one preferred embodiment of the present invention, the ceramide-containing composition of the present invention is obtained by the production method described above, and contains glucosylceramide, free ceramide, and polyphenol at a weight ratio of about 1.0:1. .0: about 1.0 ratio. Moreover, in one preferred embodiment of the present invention, the ceramide-containing composition of the present invention can contain at least about 10 mg of resveratrol per about 100 g of the composition of the present invention by being obtained by the method described above. .
 本願発明の方法により製造されたセラミド含有組成物は、様々な用途に適用または配合することができる。用途として、例えば、化粧品、医薬品、試薬、経口摂取用組成物(例えば、健康食品、機能性表示食品、特定保健用食品、サプリメント、及び特定用途食品等)などが挙げられる。 The ceramide-containing composition produced by the method of the present invention can be applied or blended for various uses. Applications include, for example, cosmetics, pharmaceuticals, reagents, and compositions for oral intake (eg, health foods, foods with function claims, foods for specified health uses, supplements, and foods for specific uses).
 一実施形態において、本願発明のセラミド含有組成物を含む製品は、賦形剤、担体、または添加剤などを含んでいてもよく、その種類としては、通常使用され、かつ薬学的に許容されるものであれば特に限定されず、またその配合量も適宜変更が可能である。例えば賦形剤としては、塩化ナトリウム、クエン酸ナトリウム等が挙げられ、担体としては、滅菌水、生理食塩水、及び各種緩衝液等が挙げられ、添加剤としては、粘ちょう剤、緩衝材、保存剤、防腐剤等を挙げることができる。 In one embodiment, the product containing the ceramide-containing composition of the present invention may contain excipients, carriers, additives, etc., the types of which are commonly used and pharmaceutically acceptable It is not particularly limited as long as it is a substance, and the blending amount thereof can be changed as appropriate. Examples of excipients include sodium chloride, sodium citrate, etc. Examples of carriers include sterilized water, physiological saline, and various buffer solutions. Preservatives, preservatives and the like can be mentioned.
 一実施形態において、本願発明のセラミド含有組成物を含む医薬品の剤型としては特に制限されるものではなく、必要に応じて適宜選択すればよいが、例えば、錠剤、カプセル剤、顆粒剤、細粒剤、散剤等の経口剤や、注射剤、坐剤、塗布剤等の非経口剤とすることができる。これらの医薬品中の本願発明のセラミド含有組成物の配合量は特に限定されるものではなく、医薬品の種類や用途に応じて適宜設定することができる。 In one embodiment, the dosage form of the pharmaceutical containing the ceramide-containing composition of the present invention is not particularly limited, and may be appropriately selected as necessary. Oral agents such as granules and powders, and parenteral agents such as injections, suppositories, and ointments can be used. The amount of the ceramide-containing composition of the present invention in these pharmaceuticals is not particularly limited, and can be appropriately set according to the type and application of the pharmaceutical.
 一実施形態において、本願発明のセラミド含有組成物を含む経口摂取用組成物(例えば、健康食品、機能性表示食品、特定保健用食品、サプリメント、及び特定用途食品等)は、必要に応じてデキストリン、乳糖、デンプン等の賦形剤や香料、色素、ゼラチン等とともに本願発明のセラミド含有組成物を配合させて製造することができる。これらの経口摂取用組成物に配合される本願発明のセラミド含有組成物の量は特に限定されるものではなく、経口摂取用組成物の種類や用途に応じて適宜設定することができる。また一実施形態において、これらの経口摂取用組成物にはその種類に応じて種々の成分を配合することができる。また一実施形態において、本願発明のセラミド含有組成物は通常消費される飲食品に添加することもできる。 In one embodiment, compositions for oral intake containing the ceramide-containing composition of the present invention (e.g., health foods, foods with function claims, foods for specified health uses, supplements, and foods for specified dietary uses) optionally contain dextrin. , lactose, starch, and other excipients, flavors, pigments, gelatin, etc., and the ceramide-containing composition of the present invention can be blended. The amount of the ceramide-containing composition of the present invention blended in these compositions for oral intake is not particularly limited, and can be appropriately set according to the type and use of the composition for oral intake. In one embodiment, these compositions for oral ingestion can contain various ingredients depending on the type. In one embodiment, the ceramide-containing composition of the present invention can also be added to foods and drinks that are normally consumed.
 一実施形態において、本願発明のセラミド含有組成物は、化粧品、医薬品および医薬部外品を含む皮膚外用剤に配合することもできる。例えば、本願発明のセラミド含有組成物は、例えば、化粧水、乳液、クリーム、ローション、石鹸、洗顔料、入浴剤、オーデコロン、化粧オイル、日焼け・日焼け止めローション、パウダー、ファンデーション、香水、パック、アイクリーム、アイシャドー、マスカラ、アイライナー、口紅、リップクリーム、シャンプー、リンス、染毛剤、軟膏剤、クリーム剤、外用液剤等に配合することができる。 In one embodiment, the ceramide-containing composition of the present invention can also be incorporated into external skin preparations including cosmetics, pharmaceuticals, and quasi-drugs. For example, the ceramide-containing composition of the present invention can be used for skin lotions, milky lotions, creams, lotions, soaps, facial cleansers, bath agents, eau de colognes, cosmetic oils, suntan/sunscreen lotions, powders, foundations, perfumes, packs, eye creams, etc. It can be incorporated into creams, eye shadows, mascaras, eyeliners, lipsticks, lip balms, shampoos, rinses, hair dyes, ointments, creams, liquids for external use, and the like.
 本願発明の一実施形態において、本願発明のセラミド含有組成物を含む皮膚外用剤(化粧品、医薬品および医薬部外品を含む)には、本願発明のセラミド含有組成物の作用を損なわない範囲において、通常の皮膚外用剤に用いられる各種成分、例えば、界面活性剤、加脂剤、毛髪保護剤、保湿剤、高分子類、紫外線吸収剤、金属封鎖剤、溶剤、pH調節剤、ビタミン類、酸化防止剤、酸化防止助剤、防腐剤、香料、油性成分、高級アルコール、脂肪酸、極性脂質、抗菌成分、粘度調整剤、色素などを配合できる。 In one embodiment of the present invention, external skin preparations (including cosmetics, pharmaceuticals, and quasi-drugs) containing the ceramide-containing composition of the present invention contain: Various ingredients used in usual external preparations for skin, e.g., surfactants, fatliquors, hair protectants, moisturizers, polymers, UV absorbers, sequestering agents, solvents, pH adjusters, vitamins, oxidation Antioxidants, antioxidant aids, preservatives, fragrances, oily components, higher alcohols, fatty acids, polar lipids, antibacterial components, viscosity modifiers, pigments, and the like can be blended.
 本願発明の一実施形態において、本願発明のセラミド含有組成物は、スプレードライ、凍結乾燥、または真空乾燥し、これを粉末、顆粒、または溶液にすることで皮膚外用剤、飲食品、医薬品などに容易に含有させることができる。 In one embodiment of the present invention, the ceramide-containing composition of the present invention is spray-dried, freeze-dried, or vacuum-dried, and then made into powder, granules, or a solution for use in external skin preparations, food and drink, pharmaceuticals, and the like. can be easily included.
 本明細書において「または」は、文章中に列挙されている事項の「少なくとも1つ以上」を採用できるときに使用される。「もしくは」も同様である。本明細書において「2つの値」の「範囲内」と明記した場合、その範囲には2つの値自体も含む。
 本明細書において引用された、科学文献、特許、特許出願などの参考文献は、その全体が、各々具体的に記載されたのと同じ程度に本明細書において参考として援用される。
In this specification, "or" is used when "at least one or more" of the items listed in the sentence can be employed. The same applies to "or". When we say "within a range" of "two values" herein, the range includes the two values themselves.
All references, such as scientific articles, patents, patent applications, etc., cited herein are hereby incorporated by reference in their entireties to the same extent as if each were specifically set forth.
 以上、本開示を、理解の容易のために好ましい実施形態を示して説明してきた。以下に、実施例に基づいて本開示を説明するが、上述の説明および以下の実施例は、例示の目的のみに提供され、本開示を限定する目的で提供したのではない。従って、本開示の範囲は、本明細書に具体的に記載された実施形態にも実施例にも限定されず、特許請求の範囲によってのみ限定される。 In the above, the present disclosure has been described by showing preferred embodiments for easy understanding. While the present disclosure will now be described based on the examples, the foregoing description and the following examples are provided for illustrative purposes only and not for the purpose of limiting the present disclosure. Accordingly, the scope of the present disclosure is not limited to the embodiments or examples specifically described herein, but only by the claims.
(実施例1:ワイン澱中のセラミド分子種)
 ワイン澱(Bitartrate)50gを60℃の水で1時間洗浄し、残渣物を得た。この残渣物について、95%エタノールを用いて40℃で6時間にわたって抽出した。この抽出物中におけるセラミド分子種について、同じく大豆から得られたセラミド分子種とその組成を比較した。結果を図1に示す。この結果からわかるとおり、大豆から得られたセラミドはグルコシルセラミドのみであり、フリーセラミドは含まれない一方で、ワイン澱から得られたセラミドにはグルコシルセラミドおよびフリーセラミドの両方が含まれる。大豆セラミドは、長良サイエンス株式会社製の大豆由来グルコシルセラミド純品を使用した。
(Example 1: Ceramide molecular species in wine sediment)
50 g of wine lees (Bitartrate) was washed with water at 60° C. for 1 hour to obtain a residue. The residue was extracted with 95% ethanol at 40° C. for 6 hours. The composition of ceramide molecular species in this extract was compared with ceramide molecular species similarly obtained from soybean. The results are shown in FIG. As can be seen from these results, ceramide obtained from soybean is only glucosylceramide and does not contain free ceramide, while ceramide obtained from wine starch contains both glucosylceramide and free ceramide. As soybean ceramide, pure soybean-derived glucosylceramide manufactured by Nagara Science Co., Ltd. was used.
 またワイン澱抽出物とワイン自体に含まれるセラミド分子種とその量を確認した結果が図2である。この結果から、ワイン自体にはフリーセラミドおよびグルコシルセラミドともに含まれないものの、ワイン澱から得られた抽出物中には、フリーセラミドおよびグルコシルセラミドともに含まれることがわかる。 Fig. 2 shows the results of confirming the ceramide molecular species and their amounts contained in the wine lees extract and the wine itself. From this result, it can be seen that wine itself contains neither free ceramide nor glucosylceramide, but the extract obtained from wine lees contains both free ceramide and glucosylceramide.
(実施例2:洗浄工程の検討1)
 本実施例では、ワイン澱から抽出物を得る際の、原料となるワイン澱の洗浄工程について検討した。図3には、本実施例において検討したワイン澱抽出物(図中、「Wセラミドエキス」)の製法を示した。図3左では、ワイン澱から95%エタノールを用いてWセラミドエキスを抽出し(60℃、6時間)、その後その残渣物からさらに60%エタノールを用いてWセラミドエキスを抽出した(60℃、3時間)。図3右では、50%エタノールを用いてワイン澱を洗浄し(40℃、1時間)、その後、洗浄後の残渣物から95%エタノールを用いてWセラミドエキスを抽出した(60℃、6時間)。結果を図4および図5に示す。図4では各成分の含有量(mg)を、図5では各成分の割合を示した。
(Example 2: Examination of cleaning process 1)
In this example, the process of washing wine lees, which is a raw material, when obtaining an extract from wine lees was investigated. FIG. 3 shows a method for producing the wine lees extract (“W ceramide extract” in the figure) investigated in this example. On the left side of FIG. 3, W ceramide extract was extracted from wine starch using 95% ethanol (60° C., 6 hours), and then W ceramide extract was further extracted from the residue using 60% ethanol (60° C., 6 hours). 3 hours). In the right part of FIG. 3, wine lees were washed with 50% ethanol (40° C., 1 hour), and then W ceramide extract was extracted from the residue after washing with 95% ethanol (60° C., 6 hours). ). The results are shown in FIGS. 4 and 5. FIG. FIG. 4 shows the content (mg) of each component, and FIG. 5 shows the ratio of each component.
 この図からもわかるとおり、95%エタノール抽出に続けて60%エタノール抽出をした場合には、夾雑物が多く残ってしまう。一方で、初めに50%エタノールを用いてワイン澱を洗浄し、続けて95%エタノール抽出を行った場合には、夾雑物を減らすことができた。 As you can see from this figure, when 95% ethanol extraction is followed by 60% ethanol extraction, many contaminants remain. On the other hand, contaminants could be reduced when the wine lees were first washed with 50% ethanol followed by 95% ethanol extraction.
(実施例3:洗浄工程の検討2)
 実施例2において、はじめにエタノール抽出を行うよりもワイン澱の洗浄を行ったほうが夾雑物を除去できることがわかったため、続いて、洗浄溶液の検討を行った。本実施例においては、水、10%エタノール、30%エタノール、または50%エタノールを用いてワイン澱を洗浄し(いずれも40℃で3時間)、その後、洗浄後の残渣物から95%エタノールを用いてWセラミドエキスを抽出した(40℃、6時間)(図6)。結果を図7に示す。
(Example 3: Examination of cleaning process 2)
In Example 2, it was found that impurities can be removed more effectively by washing the wine lees than by first extracting it with ethanol. Therefore, washing solutions were investigated. In this example, wine lees were washed with water, 10% ethanol, 30% ethanol, or 50% ethanol (both at 40 ° C. for 3 hours), and then 95% ethanol was removed from the residue after washing. was used to extract W ceramide extract (40° C., 6 hours) (FIG. 6). The results are shown in FIG.
 この図からもわかるとおり、50%エタノールで洗浄した場合に夾雑物を多く減らすことができたが、セラミド量やポリフェノール量も減少してしまった。また50%エタノールで洗浄した場合には、得られたWセラミドエキスがワイン色ではなくなっていた(図示せず)。一方で、水で洗浄した場合には、50%エタノールで洗浄した場合と比べて夾雑物の量は多いものの、セラミド量やポリフェノール量は多く残り、夾雑物の量も10%や30%のエタノールで洗浄した場合と比べて減少することができた。このことから洗浄溶液は水が最適であることがわかった。 As you can see from this figure, when washing with 50% ethanol, we were able to reduce a lot of contaminants, but the amount of ceramide and polyphenol also decreased. Further, when washed with 50% ethanol, the obtained W ceramide extract lost its wine color (not shown). On the other hand, when washed with water, although the amount of contaminants is greater than when washed with 50% ethanol, a large amount of ceramide and polyphenol remain, and the amount of contaminants is also 10% or 30% ethanol. was able to be reduced compared to the case of washing with From this, it was found that water is the most suitable cleaning solution.
(実施例4:洗浄温度の検討)
 実施例3において、水での洗浄が最適であることがわかったため、続いて、洗浄温度の検討を行った。本実施例においては、40℃、または60℃の水を用いてワイン澱を洗浄し(いずれも500ml、3時間)、その後、洗浄後の残渣物から95%エタノールを用いてWセラミドエキスを抽出した(40℃、6時間)(図8)。結果を図9に示す。
 この図からもわかるとおり、60℃で洗浄した場合には、40℃で洗浄した場合に比べて夾雑物(図中、「others」で示す)を大幅に減らすことができた。
(Example 4: Examination of washing temperature)
In Example 3, it was found that washing with water was optimal, so the washing temperature was subsequently investigated. In this example, wine lees were washed with water at 40° C. or 60° C. (both 500 ml, 3 hours), and then W ceramide extract was extracted from the residue after washing with 95% ethanol. (40° C., 6 hours) (FIG. 8). The results are shown in FIG.
As can be seen from this figure, contaminants (indicated by "others" in the figure) were significantly reduced when washed at 60°C compared to when washed at 40°C.
(実施例5:洗浄時間の検討)
 実施例4において、ワイン澱を水で洗浄する場合には60℃で行うのが最適であることがわかったため、続いて、洗浄時間の検討を行った。本実施例においては、30分、60分、180分にわたってワイン澱を洗浄し(いずれも500ml、60℃)、その後、洗浄後の残渣物から95%エタノールを用いてWセラミドエキスを抽出した(40℃、6時間)(図10)。結果を図11に示す。
(Example 5: Examination of washing time)
In Example 4, it was found that washing the wine lees with water at 60° C. was optimal, and therefore the washing time was investigated. In this example, wine lees were washed for 30 minutes, 60 minutes, and 180 minutes (500 ml, 60° C. in each case), and then W ceramide extract was extracted from the residue after washing using 95% ethanol ( 40° C., 6 hours) (FIG. 10). The results are shown in FIG.
 この図からもわかるとおり、水で30分間洗浄した場合には、夾雑物が一番除去できた。一方で、水で60分間洗浄した場合には、夾雑物が除去されつつ、グルコシルセラミドおよびフリーセラミドの含有率が一番高くなった。このことから、洗浄時間は60分とするのが最適であることがわかった。 As you can see from this figure, contaminants were removed most when washed with water for 30 minutes. On the other hand, when washed with water for 60 minutes, the contents of glucosylceramide and free ceramide became the highest while impurities were removed. From this, it was found that the optimal washing time is 60 minutes.
(実施例6:加水量の検討)
 実施例4および5において、ワイン澱を水で洗浄する場合には60℃で60分間にわたって行うのが最適であることがわかったため、続いて、洗浄の際の加水量の検討を行った。本実施例においては、50g、60g、75gのワイン澱に対して500mlの水で洗浄し(それぞれ10倍加水、8.3倍加水、6.7倍加水。いずれも60℃で1時間)、その後、洗浄後の残渣物から95%エタノールを用いてWセラミドエキスを抽出した(40℃、6時間)(図12)。結果を図13に示す。
(Example 6: Examination of amount of water added)
In Examples 4 and 5, it was found that washing the wine lees with water at 60° C. for 60 minutes was optimal, so the amount of water added during washing was investigated. In this example, 50 g, 60 g, and 75 g of wine lees were washed with 500 ml of water (10 times water, 8.3 times water, and 6.7 times water, each at 60° C. for 1 hour), Thereafter, W ceramide extract was extracted from the residue after washing using 95% ethanol (40° C., 6 hours) (FIG. 12). The results are shown in FIG.
 この図からもわかるとおり、10倍加水(ワイン澱50g、水500ml)で洗浄した場合には、8.3倍加水(ワイン澱60g、水500ml)、6.7倍加水(ワイン澱75g、水500ml)の場合に比べて夾雑物(図中、「others」で示す)を大幅に減らすことができた。 As can be seen from this figure, when washing with 10 times water (50 g of wine lees, 500 ml of water), 8.3 times water (60 g of wine lees, 500 ml of water), 6.7 times water (75 g of wine lees, water 500 ml), contaminants (indicated by "others" in the figure) could be greatly reduced.
(実施例7:pH調整の検討)
 実施例2~6において、ワイン澱からセラミド抽出物を得る際には、ワイン澱を10倍加水量の60℃の水で60分間にわたって洗浄するのが最適であることがわかったため、続いて、エタノール抽出によって得られたWセラミドエキスのpHの検討を行った。本実施例においては、エタノール抽出によって得られたWセラミドエキスに対して、酒石酸、クエン酸、または炭酸ナトリウムを添加し、さらに賦形剤(シクロデキストリン)を添加した後、フリーズドライによって粉末化した場合の粉末色を確認した(図14)。結果を図15に示す。
(Example 7: Examination of pH adjustment)
In Examples 2 to 6, when obtaining a ceramide extract from wine lees, it was found that it was optimal to wash the wine lees with 10 times the amount of water at 60 ° C. for 60 minutes. The pH of the W ceramide extract obtained by extraction was examined. In this example, tartaric acid, citric acid, or sodium carbonate was added to the W ceramide extract obtained by ethanol extraction, and then an excipient (cyclodextrin) was added, followed by freeze-drying into powder. The powder color in the case was confirmed (Fig. 14). The results are shown in FIG.
 図15からもわかるとおり、抽出エキスをpH調整することにより、望ましい粉末の色に調整することが可能であることがわかった。特にクエン酸または酒石酸でpH4.0またはpH3.5に調整した場合には、ワイン色の粉末を得ることができた。 As can be seen from Fig. 15, it was found that it was possible to adjust the color of the powder to a desired color by adjusting the pH of the extracted extract. Especially when the pH was adjusted to 4.0 or 3.5 with citric acid or tartaric acid, a wine-colored powder could be obtained.
(実施例8:細胞増殖試験)
 本願発明のセラミド含有組成物による細胞増殖効果を調べるため、ヒト表皮細胞(HaCaT細胞)を用いて細胞増殖試験を行った。ヒト表皮細胞(HaCaT細胞)を96wellプレートに播種し、播種24時間後に、ワイン澱から得た様々な濃度のセラミド抽出物を含む培地で培養した。培養3時間後に、細胞増殖を測定した。細胞増殖はCell
 Counting Kit 8(株式会社同人化学研究所製)を用いて測定した。結果を図16に示す。
(Example 8: Cell proliferation test)
In order to examine the cell proliferation effect of the ceramide-containing composition of the present invention, a cell proliferation test was conducted using human epidermal cells (HaCaT cells). Human epidermal cells (HaCaT cells) were seeded on a 96-well plate, and 24 hours after seeding, they were cultured in a medium containing various concentrations of ceramide extract obtained from wine lees. Cell proliferation was measured after 3 hours of culture. cell proliferation
It was measured using Counting Kit 8 (manufactured by Dojin Kagaku Kenkyusho Co., Ltd.). The results are shown in FIG.
 これにより、ワイン澱から得られたセラミド抽出物は、ケラチノサイト細胞(HaCaT細胞)において、細胞増殖を促進させることがわかった(図16の0.01~1μg/mL添加群を参照)。 As a result, it was found that the ceramide extract obtained from wine lees promotes cell proliferation in keratinocyte cells (HaCaT cells) (see 0.01-1 μg/mL addition group in FIG. 16).
(実施例9:レスベラトロール量測定)
 本実施例では、本願発明のセラミド含有組成物中のレスベラトロール量を測定した。レスベラトロールは抗酸化作用を持つポリフェノールの1種であり、赤ワインに含まれる成分として知られている。レスベラトロールを摂取することで、細胞の酸化を防ぎ、肌の弾力を改善するなどの効果が期待される。本実施例では、赤ワイン、ワイン澱(ワインクリスタル)、セラミド含有組成物(ワインセラミド)に含まれるレスベラトロールの量を、それぞれHPLCを用いて測定した。結果を図17に示す。
(Example 9: resveratrol amount measurement)
In this example, the amount of resveratrol in the ceramide-containing composition of the present invention was measured. Resveratrol is one of polyphenols with antioxidant action and is known as a component contained in red wine. By ingesting resveratrol, effects such as preventing cell oxidation and improving skin elasticity are expected. In this example, the amount of resveratrol contained in red wine, wine lees (wine crystals), and ceramide-containing composition (wine ceramide) was measured using HPLC. The results are shown in FIG.
 この図からも明らかなとおり、本願発明のセラミド含有組成物(ワインセラミド)に含まれるレスベラトロール量は赤ワインまたはワイン澱(ワインクリスタル)に含まれるレスベラトロール量と比較して顕著に増加していることがわかる。 As is clear from this figure, the amount of resveratrol contained in the ceramide-containing composition (wine ceramide) of the present invention is significantly increased compared to the amount of resveratrol contained in red wine or wine sediment (wine crystals). It can be seen that
(実施例10:ワインセラミドによる各種遺伝子マーカーの発現増強効果)
 ヒトケラチノサイト細胞株(HaCaT)を1×10 cells/wellの細胞数で12wellプレートに播種し、10% FBS含有のDMEM培地で培養した(37℃、5% CO)。オーバーナイトで培養した後、DMSOに溶かしたワインセラミドおよび他の原料由来のセラミド(表1)を所定の濃度で添加したDMEM培地(FBSフリー)で72時間培養した(DMSOの最終添加濃度は0.1%)。他の原料由来のセラミドは、表1に記載した各メーカーから購入したものを利用した。ワインセラミドは、実施例2~6に示した最適な手法(10倍加水による60℃、60分の水洗浄および40℃、6時間の95%エタノール抽出)によって抽出した。
Figure JPOXMLDOC01-appb-T000001
(Example 10: Expression enhancement effect of various gene markers by wine ceramide)
A human keratinocyte cell line (HaCaT) was seeded in a 12-well plate at a cell number of 1×10 5 cells/well and cultured in DMEM medium containing 10% FBS (37° C., 5% CO 2 ). After overnight culture, the cells were cultured for 72 hours in DMEM medium (FBS-free) supplemented with wine ceramide dissolved in DMSO and ceramides derived from other raw materials (Table 1) at predetermined concentrations (the final concentration of DMSO added was 0). .1%). Ceramides derived from other raw materials were purchased from manufacturers listed in Table 1. Wine ceramides were extracted by the optimized procedure shown in Examples 2-6 (water wash with 10 times water at 60°C for 60 minutes and 95% ethanol extraction at 40°C for 6 hours).
Figure JPOXMLDOC01-appb-T000001
 DMSOの最終濃度が0.1%となるように添加したDMEM培地(FBSフリー)をコントロールとして用いた。72時間培養後、細胞からmRNAを回収し、cDNAを作成した。これを用いて、qPCRによって各マーカーのmRNA発現を測定した。評価した各マーカーは以下のとおりである。
・分化マーカー;Pro-Filaggrin、Loricrin
・セラミド合成経路マーカー; Serine-Palmitoyl Transferase
A DMEM medium (FBS-free) supplemented with DMSO to a final concentration of 0.1% was used as a control. After culturing for 72 hours, mRNA was collected from the cells and cDNA was prepared. Using this, the mRNA expression of each marker was measured by qPCR. Each marker evaluated is as follows.
・Differentiation markers; Pro-Filaggrin, Loricrin
・Ceramide synthesis pathway marker; Serine-Palmitoyl Transferase
 結果を図18~21に示した。図18に示すとおり、ワインセラミドはコントロールと比較して、分化マーカーであるPro-Filaggrin(肌の角質層を形成するタンパク質。天然保湿因子(NMF)の原料)、およびLoricrin(角質層を正常に形成するための骨組みとなるタンパク質)のmRNA発現量を増加させた。これにより、ワインセラミドはケラチノサイト分化を促進することがわかる。 The results are shown in Figures 18-21. As shown in FIG. 18, wine ceramide was effective in normalizing the differentiation marker Pro-filagrin (a protein that forms the stratum corneum of the skin. A raw material of natural moisturizing factor (NMF)) and Loricrin (a protein that forms the stratum corneum of the skin. protein that serves as a scaffold for formation) increased the mRNA expression level. This indicates that wine ceramide promotes keratinocyte differentiation.
 また図19に示すとおり、ワインセラミドはコントロールと比較して、セラミド合成経路マーカーであるSPT:Serine-Palmitoyl Transferase(セラミド de novo合成経路の酵素)のmRNA発現量を増加させた。これにより、ワインセラミドはセラミド合成経路を促進することがわかる。 In addition, as shown in FIG. 19, wine ceramide increased the mRNA expression level of the ceramide synthesis pathway marker SPT: Serine-Palmitoyl Transferase (an enzyme of the ceramide de novo synthesis pathway) compared to the control. This indicates that wine ceramide promotes the ceramide synthesis pathway.
 また図20には、本発明のワインセラミドと、グルコシルセラミドおよびフリーセラミドとを比較した場合のPro-Filaggrin mRNA発現量およびSPT mRNA発現量を示した。グルコシルセラミドおよびフリーセラミドの添加量はワインセラミドに含まれるグルコシルセラミドおよびフリーセラミドの同等量で算出し、具体的には、ワインセラミド1μg/mL、グルコシルセラミド0.075μg/mL、フリーセラミド0.035μg/mLを用いた。グルコシルセラミドおよびフリーセラミドは、ワインセラミドから単離したものを使用した。この図からもわかるとおり、ワインセラミドはグルコシルセラミド単独またはフリーセラミド単独の場合よりもそれぞれのmRNA発現量の増加効果が高い。 FIG. 20 also shows the Pro-filagrin mRNA expression level and SPT mRNA expression level when comparing the wine ceramide of the present invention with glucosylceramide and free ceramide. The amounts of glucosylceramide and free ceramide added were calculated based on the equivalent amounts of glucosylceramide and free ceramide contained in wine ceramide. /mL was used. Glucosylceramide and free ceramide used were those isolated from wine ceramide. As can be seen from this figure, wine ceramide is more effective in increasing the respective mRNA expression levels than glucosylceramide alone or free ceramide alone.
 また図21には、本発明のワインセラミドと、ワイン以外の原料から得られた各セラミド(米セラミド、パインセラミド、およびこんにゃくセラミド)とを比較した場合のPro-Filaggrin mRNA発現量およびSPT mRNA発現量を示した。各セラミドの組成は表1に示したとおりである。この図からもわかるとおり、ワインセラミドは米セラミドまたはパインセラミドよりもそれぞれのmRNA発現量の増加効果が高い。 FIG. 21 also shows the Pro-Filaggrin mRNA expression level and SPT mRNA expression when comparing the wine ceramide of the present invention with each ceramide obtained from raw materials other than wine (rice ceramide, pine ceramide, and konjac ceramide). indicated the quantity. The composition of each ceramide is as shown in Table 1. As can be seen from this figure, wine ceramide is more effective in increasing the respective mRNA expression levels than rice ceramide or pine ceramide.
(実施例11:ケラチノサイトに対するワインセラミドの効果)
 トランスウェルを用いて3D培養した初代培養ケラチノサイトにおいて、ワインセラミドの有効性を評価した。ワインセラミドは実施例10と同様のものを用いた。トランスウェルの角層側(Upperウェル)および基底膜側(Bottomウェル)にそれぞれワインセラミド含有の培地を所定の時間添加して培養した。対照群として、DMSO 0.1%含有の培地にて培養した。各培地で培養した後、3D培養した初代培養ケラチノサイトの凍結切片を作成し、ヘマトキシリン・エオシン染色および抗セラミド抗体を用いた免疫染色を行った。
(Example 11: Effect of wine ceramide on keratinocytes)
The efficacy of wine ceramide was evaluated in primary cultured keratinocytes cultured in 3D using Transwell. The same wine ceramide as in Example 10 was used. A culture medium containing wine ceramide was added to each of the stratum corneum side (upper well) and the basement membrane side (bottom well) of the transwell for a predetermined period of time and cultured. As a control group, the cells were cultured in a medium containing 0.1% DMSO. After culturing in each medium, frozen sections of 3D-cultured primary cultured keratinocytes were prepared and subjected to hematoxylin-eosin staining and immunostaining using an anti-ceramide antibody.
 ヘマトキシリン・エオシン染色した切片を位相差顕微鏡下で観察し、表皮層の厚さを測定した結果を図22に示した。この結果からわかるとおり、ワインセラミド処理により、皮膚の厚さが増加している。皮膚の厚さについては、加齢とともに皮膚のターンオーバーが低下して薄くなることが知られているため、今回の結果は、ワインセラミド処理によってケラチノサイトの増加および分化が促進され、皮膚のターンオーバーも促進したことが考えられる。 The hematoxylin/eosin-stained sections were observed under a phase-contrast microscope, and the results of measuring the thickness of the epidermal layer are shown in FIG. As can be seen from the results, the wine ceramide treatment increases the thickness of the skin. As for skin thickness, it is known that skin turnover decreases and becomes thinner with aging. may have also promoted
 また抗セラミド抗体で免疫染色した切片を蛍光顕微鏡下で観察し、表皮層中のセラミド含量を測定した結果を図23に示した。この結果からわかりとおり、対照群と比較して、ワインセラミド処理した3D培養ケラチノサイトでは、免疫染色部分が拡大しており、セラミド量が増加している。実施例10に示したとおり、平面培養(2D培養)において、セラミド合成経路マーカー(SPT)のmRNA発現量が増加していたことから、本実施例におけるセラミド量の増加は、セラミドの取り込みだけではなく、セラミドの新規合成が増加したことがわかる。 Sections immunostained with an anti-ceramide antibody were also observed under a fluorescence microscope, and the results of measuring the ceramide content in the epidermal layer are shown in FIG. As can be seen from these results, in the 3D cultured keratinocytes treated with wine ceramide, the immunostained area is enlarged and the amount of ceramide is increased compared to the control group. As shown in Example 10, in the planar culture (2D culture), the mRNA expression level of the ceramide synthesis pathway marker (SPT) was increased. However, it can be seen that the new synthesis of ceramide increased.
 (注記)
 以上のように、本開示の好ましい実施形態を用いて本開示を例示してきたが、本開示は、特許請求の範囲によってのみその範囲が解釈されるべきであることが理解される。本明細書において引用した特許、特許出願及び他の文献は、その内容自体が具体的に本明細書に記載されているのと同様にその内容が本明細書に対する参考として援用されるべきであることが理解される。本願は、日本国特許庁に2021年10月15日に出願された特願2021-169620、および2022年6月10日に出願された特願2022-94514に対して優先権主張をするものであり、その内容はその全体があたかも本願の内容を構成するのと同様に参考として援用される。
(Note)
While the present disclosure has been illustrated using the preferred embodiments thereof, it is understood that the present disclosure is to be construed in scope only by the claims. The patents, patent applications and other publications cited herein are hereby incorporated by reference in their entirety to the same extent as if the content itself were specifically set forth herein. It is understood. This application claims priority to Japanese Patent Application No. 2021-169620 filed on October 15, 2021 and Japanese Patent Application No. 2022-94514 filed on June 10, 2022 with the Japan Patent Office. , the contents of which are hereby incorporated by reference as though they constitute the subject matter of this application in their entirety.
 本願発明により、ワイン発酵粕由来のセラミド含有組成物を提供することができる。また本願発明の方法によれば、ワイン発酵粕を原料として、夾雑物を除去しながらセラミド組成物の安定的な抽出が可能となり、またセラミド組成物の色も制御することができる。さらに本願発明のセラミド組成物はフリーセラミドを含み、ワイン発酵粕という安全性の高い天然の材料を使用しているため、機能性食品や化粧品などに配合しても、人体に対して悪影響を及ぼすことなく、安全性に優れているため、化粧品、医薬品、及び医薬部外品などの分野において有用である。 The present invention can provide a ceramide-containing composition derived from wine fermentation lees. Moreover, according to the method of the present invention, it is possible to stably extract a ceramide composition from wine fermentation lees while removing contaminants, and to control the color of the ceramide composition. Furthermore, the ceramide composition of the present invention contains free ceramide and uses highly safe natural materials such as wine fermented lees. It is useful in fields such as cosmetics, pharmaceuticals, and quasi-drugs because it has excellent safety.

Claims (32)

  1.  ポリフェノールおよびセラミドを含有する美容用および/または経口摂取用組成物。 A cosmetic and/or oral composition containing polyphenols and ceramides.
  2.  前記セラミドが、フリーセラミドおよびグルコシルセラミドを含む、請求項1に記載の組成物。 The composition according to claim 1, wherein the ceramide comprises free ceramide and glucosylceramide.
  3.  前記組成物が、少なくとも約1重量%のフリーセラミドを含む、請求項2に記載の組成物。 The composition according to claim 2, wherein the composition contains at least about 1% by weight of free ceramide.
  4.  前記組成物が、少なくとも約1重量%のグルコシルセラミドを含む、請求項2または3に記載の組成物。 The composition according to claim 2 or 3, wherein said composition comprises at least about 1% by weight of glucosylceramide.
  5.  前記組成物が、少なくとも約1重量%のポリフェノールを含む、請求項1~4のいずれか一項に記載の組成物。 The composition according to any one of claims 1 to 4, wherein the composition contains at least about 1% by weight of polyphenols.
  6.  前記組成物におけるフリーセラミド、グルコシルセラミド、及びポリフェノールの重量比が、約0.7~約2.4:約1.0:約1.4~約11.0である、請求項1~5のいずれか一項に記載の組成物。 of claims 1-5, wherein the weight ratio of free ceramide, glucosylceramide, and polyphenol in the composition is about 0.7 to about 2.4: about 1.0: about 1.4 to about 11.0. A composition according to any one of the preceding claims.
  7.  前記組成物におけるフリーセラミド、グルコシルセラミド、及びポリフェノールの重量比が、約1.0:約1.0:約1.0である、請求項1~6のいずれか一項に記載の組成物。 The composition according to any one of claims 1 to 6, wherein the weight ratio of free ceramide, glucosylceramide and polyphenol in the composition is about 1.0: about 1.0: about 1.0.
  8.  前記組成物のpHが約5未満である、請求項1~7のいずれか一項に記載の組成物。 The composition according to any one of claims 1 to 7, wherein the composition has a pH of less than about 5.
  9.  約100gあたり少なくとも約10mgのレスベラトロールを含む、請求項1~8のいずれか一項に記載の組成物。 The composition according to any one of claims 1 to 8, comprising at least about 10 mg resveratrol per about 100 g.
  10.  食品用である、請求項1~9のいずれか一項に記載の組成物。 The composition according to any one of claims 1 to 9, which is for food.
  11.  化粧料用である、請求項1~9のいずれか一項に記載の組成物。 The composition according to any one of claims 1 to 9, which is used for cosmetics.
  12.  前記ポリフェノールおよび前記セラミドが、ワイン発酵粕由来である、請求項1~11のいずれか一項に記載の組成物。 The composition according to any one of claims 1 to 11, wherein the polyphenol and the ceramide are derived from wine fermentation lees.
  13.  ケラチノサイトの分化を促進するための、請求項1~12のいずれか一項に記載の組成物。 The composition according to any one of claims 1 to 12, for promoting keratinocyte differentiation.
  14.  セラミド合成を促進するための、請求項1~13のいずれか一項に記載の組成物。 The composition according to any one of claims 1 to 13, for promoting ceramide synthesis.
  15.  ワイン発酵粕由来のセラミド含有組成物。 A ceramide-containing composition derived from wine fermentation lees.
  16.  前記セラミド含有組成物が、少なくとも約1重量%のフリーセラミドを含む、請求項15に記載の組成物。 The composition according to claim 15, wherein the ceramide-containing composition contains at least about 1% by weight of free ceramide.
  17.  前記セラミド含有組成物が、少なくとも約1重量%のグルコシルセラミドを含む、請求項15または16に記載の組成物。 The composition according to claim 15 or 16, wherein said ceramide-containing composition comprises at least about 1% by weight of glucosylceramide.
  18.  前記セラミド含有組成物が、少なくとも約1重量%のポリフェノールを含む、請求項15~17のいずれか一項に記載の組成物。 The composition according to any one of claims 15 to 17, wherein the ceramide-containing composition contains at least about 1% by weight of polyphenols.
  19.  前記組成物におけるフリーセラミド、グルコシルセラミド、及びポリフェノールの重量比が、約0.7~約2.4:約1.0:約1.4~約11.0である、請求項15~18のいずれか一項に記載の組成物。 of claims 15-18, wherein the weight ratio of free ceramide, glucosylceramide, and polyphenol in the composition is about 0.7 to about 2.4: about 1.0: about 1.4 to about 11.0. A composition according to any one of the preceding claims.
  20.  前記セラミド含有組成物におけるフリーセラミド、グルコシルセラミド、及びポリフェノールの重量比が、約1.0:約1.0:約1.0である、請求項15~19のいずれか一項に記載の組成物。 20. The composition of any one of claims 15-19, wherein the weight ratio of free ceramide, glucosylceramide, and polyphenol in the ceramide-containing composition is about 1.0: about 1.0: about 1.0. thing.
  21.  前記セラミド含有組成物のpHが約5未満である、請求項15~20のいずれか一項に記載の組成物。 The composition according to any one of claims 15 to 20, wherein the ceramide-containing composition has a pH of less than about 5.
  22.  約100gあたり少なくとも約10mgのレスベラトロールを含む、請求項15~21のいずれか一項に記載の組成物。 The composition according to any one of claims 15-21, comprising at least about 10 mg resveratrol per about 100 g.
  23.  食品用である、請求項15~22のいずれか一項に記載の組成物。 The composition according to any one of claims 15 to 22, which is for food.
  24.  化粧料用である、請求項13~22のいずれか一項に記載の組成物。 The composition according to any one of claims 13 to 22, which is used for cosmetics.
  25.  ケラチノサイトの分化を促進するための、請求項15~24のいずれか一項に記載の組成物。 The composition according to any one of claims 15 to 24, for promoting keratinocyte differentiation.
  26.  セラミド合成を促進するための、請求項15~24のいずれか一項に記載の組成物。 The composition according to any one of claims 15 to 24, for promoting ceramide synthesis.
  27.  セラミド含有組成物を製造する方法であって、
     ワイン発酵粕を洗浄する工程と、
     該洗浄によって得られた残渣物を極性溶媒で抽出する工程と
    を含む、方法。
    A method for producing a ceramide-containing composition, comprising:
    A step of washing the wine fermented lees;
    and extracting the residue obtained by said washing with a polar solvent.
  28.  前記極性溶媒がエタノールを含む、請求項27に記載の方法。 The method according to claim 27, wherein the polar solvent comprises ethanol.
  29.  前記エタノールの濃度が約95%である、請求項28に記載の方法。 The method according to claim 28, wherein the ethanol concentration is about 95%.
  30.  前記洗浄する工程が水によって行われる、請求項27~29のいずれか一項に記載の方法。 The method according to any one of claims 27 to 29, wherein the washing step is performed with water.
  31.  前記抽出する工程によって得られた抽出物をpH調整する工程をさらに含む、請求項27~30のいずれか一項に記載の方法。 The method according to any one of claims 27 to 30, further comprising a step of adjusting the pH of the extract obtained by the extracting step.
  32.  前記pH調整が酒石酸またはクエン酸によって行われる、請求項31に記載の方法。 The method of claim 31, wherein said pH adjustment is performed with tartaric acid or citric acid.
PCT/JP2022/038436 2021-10-15 2022-10-14 Ceramide-containing composition and method for producing same WO2023063424A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2021-169620 2021-10-15
JP2021169620 2021-10-15
JP2022094514A JP2023059809A (en) 2021-10-15 2022-06-10 Ceramide-containing composition and method for producing the same
JP2022-094514 2022-06-10

Publications (1)

Publication Number Publication Date
WO2023063424A1 true WO2023063424A1 (en) 2023-04-20

Family

ID=85987799

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2022/038436 WO2023063424A1 (en) 2021-10-15 2022-10-14 Ceramide-containing composition and method for producing same

Country Status (1)

Country Link
WO (1) WO2023063424A1 (en)

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000135071A (en) * 1998-10-30 2000-05-16 Sunstar Inc Food or pharmaceutical composition containing wine strained lee extract
JP2002238497A (en) * 2001-02-19 2002-08-27 Fancl Corp Food composition
JP2003527843A (en) * 2000-02-11 2003-09-24 コグニス・フランス・ソシエテ・アノニム Extracts from winemaking residues
JP2009165427A (en) * 2008-01-18 2009-07-30 Masaru Yoshino Method for producing food additive material
JP5013348B2 (en) * 2010-07-23 2012-08-29 宮鍋 征克 How to get sphingolipid
JP2015105272A (en) * 2013-12-03 2015-06-08 宮鍋 征克 Purple sweet potato unrefined sake distillation lees extract
WO2018021476A1 (en) * 2016-07-29 2018-02-01 株式会社 サティス製薬 Chestnut-skin extract
CN109007819A (en) * 2018-07-25 2018-12-18 广州正广生物科技有限公司 Anti- saccharification product of one kind and preparation method thereof
CN111358729A (en) * 2020-03-13 2020-07-03 猫头鹰(福州)日用品有限公司 Moisturizing mask containing red wine polyphenol and preparation method thereof
CN112042933A (en) * 2019-06-08 2020-12-08 白华 Formula of oral weight-losing food for culturing intestinal flora and improving weakness of spleen and stomach and preparation method of oral weight-losing food

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000135071A (en) * 1998-10-30 2000-05-16 Sunstar Inc Food or pharmaceutical composition containing wine strained lee extract
JP2003527843A (en) * 2000-02-11 2003-09-24 コグニス・フランス・ソシエテ・アノニム Extracts from winemaking residues
JP2002238497A (en) * 2001-02-19 2002-08-27 Fancl Corp Food composition
JP2009165427A (en) * 2008-01-18 2009-07-30 Masaru Yoshino Method for producing food additive material
JP5013348B2 (en) * 2010-07-23 2012-08-29 宮鍋 征克 How to get sphingolipid
JP2015105272A (en) * 2013-12-03 2015-06-08 宮鍋 征克 Purple sweet potato unrefined sake distillation lees extract
WO2018021476A1 (en) * 2016-07-29 2018-02-01 株式会社 サティス製薬 Chestnut-skin extract
CN109007819A (en) * 2018-07-25 2018-12-18 广州正广生物科技有限公司 Anti- saccharification product of one kind and preparation method thereof
CN112042933A (en) * 2019-06-08 2020-12-08 白华 Formula of oral weight-losing food for culturing intestinal flora and improving weakness of spleen and stomach and preparation method of oral weight-losing food
CN111358729A (en) * 2020-03-13 2020-07-03 猫头鹰(福州)日用品有限公司 Moisturizing mask containing red wine polyphenol and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SAWABE, AKIYOSHI; KAWAMURA, HARUKI; YOSHIDA, HIROKAZU; TAKEDA, RYUJI; IIDA, AKIRA; HAMAHARA, NORIMASA; KOMEMUSHI, SADAO; KAWAKAMI,: "3B019 Anti-aging effect of wine ingredients and effective use of wine compression residue", PROCEEDINGS OF THE ANNUAL MEETING OF JAPAN SOCIETY FOR BIOSCIENCE, BIOTECHNOLOGY, AND AGROCHEMISTRY (JSBBA2016), vol. 2016, 5 March 2016 (2016-03-05), pages 897, XP009546125 *
YAMASHITA SHINJI, HIGAKI CHISATO, KIKUCHI NOBUHIRO, SUZUKI DAISUKE, KINOSHITA MIKIO, MIYAZAWA TERUO: "Sake (Rice Wine) Brewing Hydrolyzes Highly Polar Sphingolipids to Ceramides and Increases Free Sphingoid Bases", JOURNAL OF OLEO SCIENCE, JAPAN OIL CHEMISTS SOCIETY, TOKYO, JP, vol. 70, no. 8, 1 January 2021 (2021-01-01), JP , pages 1147 - 1156, XP093058281, ISSN: 1345-8957, DOI: 10.5650/jos.ess21125 *

Similar Documents

Publication Publication Date Title
KR101363413B1 (en) A cosmetic composition comprising the complex extract of salicornia herbacea l. and phragmitis rhizoma
CA2821876A1 (en) Avocado flesh and/or skin extract rich in polyphenols and cosmetic, dermatological and nutraceutical compositions comprising same
EP2467134B1 (en) Skin clarifying complex, use of said complex, cosmestic or pharmaceutical composition comprising said complex and method for application thereof
JP4388289B2 (en) Skin aging prevention / improving agent and / or rough skin prevention / improving agent kit
JP2017202990A (en) Cosmetics and food and drink composition
JP6969067B2 (en) Anti-inflammatory, anti-aging and whitening agents
KR101993699B1 (en) Composition for improving skin
KR20170025375A (en) Composition for improving skin
TWI747280B (en) Fermentation product of phyllanthus emblica extract and preparation and use of the same
JP4685375B2 (en) Topical skin preparation
JP2017502087A (en) A plant extract containing, as an active ingredient, a sucrose ester used in a cosmetic composition, dermatological composition, or nutritional cosmetic composition
WO2023063424A1 (en) Ceramide-containing composition and method for producing same
KR101648148B1 (en) Cosmetic composition containing fermented graviola for improving anti-wrinkle and method of preparing the same
KR20210097239A (en) Anti-aging composition comprising functional peptides, amino acids, callus extract and fermented materials
JP2023059809A (en) Ceramide-containing composition and method for producing the same
KR102016062B1 (en) Callus extracts from Citrus junos Siebold ex Tanaka and Pyrus pyrifolia Nakai with Whitening and Anti-wrinkle effect
JP2004168732A (en) Active oxygen-scavenging agent, inhibitor for synthesis promotion/decomposition of hyaluronic acid, and aquaporin synthesis promotor
TWI779296B (en) Fermentation product of black rice extract and preparation and use of the same
KR101685829B1 (en) Method for prepareing fermented extract of mistletoe having enhanced antioxidative effect
JP2008214335A (en) Sparassis crispa extract, biaryl compound and cosmetic
KR101661288B1 (en) Composition for improving skin
KR101997231B1 (en) Cosmetic composition containing enzyme-treated honey extract
JP7233832B2 (en) hair cosmetics
KR101948661B1 (en) Cosmetic composition for skin whitening containing magnolia sieboldii extract ripened at low-temperature using bamboo charcoal
WO2023249046A1 (en) Agent for maintaining structure of hyaluronic acid

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22881119

Country of ref document: EP

Kind code of ref document: A1